<?xml version="1.0" encoding="UTF-8"?>
<svg height="778.0" width="557.949" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:1.0;" d="M62.360 53.720 L545.670 53.720 "/>
  <g begin="text">
   <text y="49.34" x="62.362,66.842,71.322,74.862,77.672,82.052,85.182,87.962,92.542,96.922,100.462,104.002,105.882,110.362,115.052,117.832,123.042,125.022,127.802,133.012,138.222,141.002,143.922,148.502,153.712,156.632" svgx:width="0.45,0.45,0.35,0.28,0.44,0.31,0.28,0.46,0.44,0.35,0.35,0.19,0.45,0.47,0.28,0.52,0.2,0.28,0.52,0.52,0.28,0.29,0.46,0.52,0.29,0.28" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Poster session 2, 20 (s1) </text>
   <text y="49.34" x="530.672,535.672,540.672" svgx:width="0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">401</text>
  </g>
  <g begin="text">
   <text y="768.0" x="355.802,363.932,368.622,370.502,373.312,375.192,380.092,381.972,386.352,389.132,393.712,397.562,399.442,403.822,406.952,411.432,414.972,416.852,420.392,423.172,425.572,430.052,434.742,437.872,442.562,447.252" svgx:width="0.81,0.47,0.19,0.28,0.19,0.49,0.19,0.44,0.28,0.46,0.38,0.19,0.44,0.31,0.45,0.35,0.19,0.35,0.28,0.24,0.45,0.47,0.31,0.47,0.47,0.19" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Multiple Sclerosis Journal</text>
   <text y="768.0" x="449.132,451.912,456.912,461.912,466.912,471.912,474.102,476.882,481.882,486.882,489.072,491.852,495.082,499.662,504.662,507.892,510.672,515.672,520.672,525.672,530.672,535.672,540.672" svgx:width="0.28,0.5,0.5,0.5,0.5,0.22,0.28,0.5,0.5,0.22,0.28,0.32,0.46,0.5,0.32,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;"> 2014; 20: (S1) 285–496</text>
  </g>
  <g begin="text">
   <text y="768.0" x="61.186,68.896,72.746,74.936,77.126,80.976,85.246,89.516,94.306,99.306,104.306,109.206,111.396,115.776,121.296" svgx:width="0.77,0.38,0.22,0.22,0.38,0.43,0.43,0.48,0.5,0.5,0.5,0.22,0.44,0.55,0.77" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">msj.sagepub.com</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.25;" d="M62.360 545.300 L94.600 545.300 "/>
  <g begin="text">
   <text y="77.103" x="62.362,66.862,70.858,73.36,77.356,79.606,81.928,88.426,92.926,95.428,99.424,103.924,106.246,108.748,112.249,114.571,119.071,123.571,127.072,130.573,133.075,137.575,140.077,144.073,146.395,148.897,153.397,156.394,160.894,165.394,169.894,174.394,176.716,181.216,185.716,189.217,191.719,194.716,199.216,203.716,207.712,210.034,214.03,218.53,222.526,225.028,229.528,233.029,235.531,239.032,241.354,245.854,248.851,251.173,255.169,257.671,260.173,264.673,267.175,271.171,275.167,277.669,279.991,282.493,285.49,287.992,291.988,294.49,297.991" svgx:width="0.5,0.44,0.28,0.44,0.25,0.25,0.72,0.5,0.28,0.44,0.5,0.25,0.28,0.39,0.25,0.5,0.5,0.39,0.39,0.28,0.5,0.28,0.44,0.25,0.28,0.5,0.33,0.5,0.5,0.5,0.5,0.25,0.5,0.5,0.39,0.28,0.33,0.5,0.5,0.44,0.25,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.39,0.25,0.5,0.33,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.28,0.33,0.28,0.44,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">data, which is possible through post-hoc analysis of clinical trials </text>
   <text y="88.101" x="62.362,68.86,73.36,77.356,80.353,84.349,86.599,90.1,94.6,98.596,103.096,105.346,109.846,113.842,116.344,120.34,122.59,129.088,133.084,136.585,138.835,142.831,147.331,149.833,152.335,156.331,160.327,162.829,166.825,171.325,173.575,177.571,181.567,184.564,189.064,192.565,196.066,198.316,200.818,205.318,209.314,211.564,215.065,217.567,222.067,226.567,231.067,233.317,237.817,242.317,246.817,251.317,253.819,257.815,260.317,262.819,267.319,271.819" svgx:width="0.72,0.5,0.44,0.33,0.44,0.25,0.39,0.5,0.44,0.5,0.25,0.5,0.44,0.28,0.44,0.25,0.72,0.44,0.39,0.25,0.44,0.5,0.28,0.28,0.44,0.44,0.28,0.44,0.5,0.25,0.44,0.44,0.33,0.5,0.39,0.39,0.25,0.28,0.5,0.44,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.5,0.5,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">where such data was collected across the study population.</text>
   <text y="99.099" x="62.362,69.364,74.368,77.365,81.361,85.357,88.354,90.856,95.356,99.352,102.853,105.85" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="99.099" x="107.614,112.483,116.983,118.747,121.249,125.749,129.745,134.245,136.747,139.249,142.246,146.746,148.51,155.512,159.508,162.505,167.005,171.001,173.998,177.499,179.263,183.259,186.76,190.261,194.761,198.757,201.259,205.255,207.757,211.753,216.253,218.017,224.515,227.017,229.519,234.019,235.783,240.283,244.783,247.78,251.281,253.783,258.283,262.783,267.283,269.047,272.044,276.04,278.542,282.538,287.038,290.539,294.535,298.036" svgx:width="0.61,0.5,0.25,0.28,0.5,0.44,0.5,0.28,0.28,0.33,0.5,0.25,0.78,0.44,0.33,0.5,0.44,0.33,0.39,0.25,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.5,0.5,0.33,0.39,0.28,0.5,0.5,0.5,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">To identify markers associated with on-study relapses </text>
   <text y="110.097" x="62.362,66.358,70.858,75.358,77.86,82.36,85.357,87.607,89.776,94.276,96.778,100.279,104.275,108.775,111.277,113.779,116.281,118.783,123.283,125.533,127.702,132.202,135.199,139.699,144.199,147.196,151.192,154.693,158.194,160.696,165.196,169.696,171.946,174.115,178.615,183.115,187.111,190.108,192.358,194.527,199.027,202.024,206.524,210.52,214.516,217.513,221.014,223.264,225.514,227.683,232.183,235.684,238.186,242.686,247.186,249.436,251.605,256.105,260.101,262.603,266.599,268.849,271.018,275.518,279.514,282.511,285.013,289.513,293.509,298.009" svgx:width="0.44,0.5,0.5,0.28,0.5,0.33,0.25,0.55,0.5,0.28,0.39,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.55,0.5,0.33,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.5,0.5,0.44,0.33,0.25,0.55,0.5,0.33,0.5,0.44,0.44,0.33,0.39,0.25,0.25,0.55,0.5,0.39,0.28,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.25,0.55,0.5,0.44,0.33,0.28,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and/or disability progression over 2-years, using data derived </text>
   <text y="121.095" x="62.362,65.359,68.356,72.856,79.858,82.108,83.179,85.681,90.181,94.177,96.427,97.498,101.998,104.5,108.496,112.492,116.488,120.988,125.488,127.738,128.809,132.805,135.802,142.804,146.305,148.555,149.626,154.126,157.123,159.373,160.444,162.946,169.444,173.944,176.194,177.265,179.767,183.763,186.598,191.098,195.094,197.344,198.415,202.411,206.911,211.411,213.913,217.909,224.911,229.411,233.911,236.908,240.904,245.404,249.4,253.9,258.4,261.901,264.151,265.222,269.722,274.222,278.218,281.719,285.715,287.965,289.036,292.033,295.03,298.027" svgx:width="0.33,0.33,0.5,0.78,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.28,0.44,0.44,0.44,0.5,0.5,0.25,0.55,0.44,0.33,0.78,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.72,0.5,0.25,0.55,0.28,0.44,0.33,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.28,0.44,0.78,0.5,0.5,0.33,0.44,0.5,0.44,0.5,0.5,0.39,0.25,0.55,0.5,0.5,0.44,0.39,0.44,0.25,0.55,0.33,0.33,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">from the placebo arms of two large contemporaneous phase III </text>
   <text y="132.093" x="62.362,65.863,68.365,72.865,77.365,79.867,83.863,87.364,89.614,92.611,99.109,104.608,109.612,112.609,119.107,124.606,126.856,130.852,135.352,139.852,142.102,148.105,154.603,161.101,166.105,169.102,175.105,183.106,186.103" svgx:width="0.39,0.28,0.5,0.5,0.28,0.44,0.39,0.25,0.33,0.72,0.61,0.56,0.33,0.72,0.61,0.25,0.44,0.5,0.5,0.25,0.67,0.72,0.72,0.56,0.33,0.67,0.89,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">studies (DEFINE and CONFIRM).</text>
   <text y="143.091" x="62.362,70.858,74.854,77.851,82.855,87.355,92.359,95.86,98.857" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="143.091" x="103.555,111.331,115.327,117.577,120.025,122.527,127.027,131.527,135.523,139.024,141.526,144.028,148.528,152.524,155.026,159.022,163.522,165.772,168.22,170.722,175.222,179.218,181.468,183.916,187.912,191.413,194.914,199.414,203.41,205.912,209.908,212.41,214.912,219.412,223.912,226.162,228.61,233.11,236.107,238.357,240.805,245.305,249.301,252.802,256.798,259.3,261.802,266.302,270.298,272.548,274.996,279.496,283.492,290.494,294.994" svgx:width="0.94,0.44,0.25,0.55,0.28,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.78,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">We investigated the association of baseline demo-</text>
   <text y="154.089" x="62.362,66.862,69.859,73.855,78.355,82.855,85.357,89.353,91.603,93.412,97.912,100.414,103.915,107.911,111.907,115.408,119.404,121.213,125.209,129.709,134.209,136.018,143.02,147.52,150.022,154.018,158.014,162.514,165.016,169.012,172.009,173.818,178.318,182.314,185.311,187.813,191.809,196.309,198.811,202.807,206.308,208.117,214.615,217.117,219.619,224.119,225.928,229.924,232.426,234.928,239.428,241.93,245.926,249.922,252.424,254.233,258.733,263.233,265.735,269.731,274.231,281.233,285.229,288.73,290.539,295.039,298.036" svgx:width="0.5,0.33,0.44,0.5,0.5,0.28,0.44,0.25,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.44,0.5,0.5,0.25,0.78,0.5,0.28,0.44,0.44,0.5,0.28,0.44,0.33,0.25,0.5,0.44,0.33,0.28,0.44,0.5,0.28,0.44,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.5,0.5,0.28,0.44,0.5,0.78,0.44,0.39,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">graphic, disease and molecular variables with clinical outcomes of </text>
   <text y="165.087" x="62.362,66.862,71.362,75.862,78.355,82.855,85.357,89.353,93.349,97.345,101.845,106.345,109.342,111.844,114.841,118.837,122.833,125.335,129.331,133.831,136.324,142.327,148.33,156.331,161.335,163.828,167.329,171.829,176.329,178.831,182.827,186.823,189.325,192.826,195.076,197.569,205.57,210.07,212.572,216.568,220.564,225.064,227.566,231.562,234.559,237.052,241.552,246.052,250.048,254.548,259.048,261.55,266.05,270.55,274.546,278.047,280.54,287.038,291.034,294.031,298.027" svgx:width="0.5,0.5,0.5,0.25,0.5,0.28,0.44,0.44,0.44,0.5,0.5,0.33,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.67,0.67,0.89,0.56,0.25,0.39,0.5,0.5,0.28,0.44,0.44,0.28,0.39,0.25,0.25,0.89,0.5,0.28,0.44,0.44,0.5,0.28,0.44,0.33,0.25,0.5,0.5,0.44,0.5,0.5,0.28,0.5,0.5,0.44,0.39,0.25,0.72,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">771 placebo-treated RRMS subjects. Molecular phenotypes were </text>
   <text y="176.085" x="62.362,66.862,70.858,73.855,76.357,80.857,84.853,89.353,91.603,93.97,96.967,99.964,104.464,111.466,113.716,116.083,122.581,127.081,131.581,134.083,138.079,140.329,142.696,147.196,149.698,154.198,158.698,163.198,165.448,167.815,174.817,180.82,187.318,193.321,195.571,197.938,202.438,205.435,209.935,212.932,215.434,217.936,220.438,224.938,229.438,231.688,234.055,238.555,242.056,244.558,249.058,253.558,255.808,257.68,264.178,267.013,270.01,274.51,281.512,285.508,288.01,291.007,293.509,298.009" svgx:width="0.5,0.44,0.33,0.28,0.5,0.44,0.5,0.25,0.55,0.33,0.33,0.5,0.78,0.25,0.55,0.72,0.5,0.5,0.28,0.44,0.25,0.55,0.5,0.28,0.5,0.5,0.5,0.25,0.55,0.78,0.67,0.72,0.72,0.25,0.55,0.5,0.33,0.5,0.33,0.28,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.39,0.28,0.5,0.5,0.25,0.55,0.72,0.33,0.33,0.5,0.78,0.44,0.28,0.33,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">derived from whole blood mRNA profiling using Affymetrix </text>
   <text y="187.083" x="62.362,68.86,72.856,77.356,81.352,84.277,90.28,94.78,97.282,101.782,108.622,110.872,113.797,120.295,124.795,129.295,133.795,136.297,140.797,144.793,148.294,150.796,154.297,157.294,161.794,164.791,167.293,171.793,175.789,180.289,182.539,183.214,187.21,191.71,196.21,199.135,203.635,208.135,212.635,217.135,219.637,224.137,228.133,231.634,234.136,237.637,240.634,243.631,246.628,250.624,254.62,256.87,257.545,261.541,266.041,270.541,273.538,278.038,282.034,286.03,290.53,294.526,298.027" svgx:width="0.72,0.44,0.5,0.44,0.25,0.67,0.5,0.28,0.5,0.76,0.25,0.25,0.72,0.5,0.5,0.5,0.28,0.5,0.44,0.39,0.28,0.39,0.33,0.5,0.33,0.28,0.5,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.5,0.5,0.5,0.5,0.28,0.5,0.44,0.39,0.28,0.39,0.33,0.33,0.33,0.44,0.44,0.25,0.55,0.44,0.5,0.5,0.33,0.5,0.44,0.44,0.5,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Gene Chip®. Hypothesis-driven and hypothesis-free approaches </text>
   <text y="198.081" x="62.362,68.86,72.856,75.853,79.849,81.748,85.744,90.244,94.744,97.246,99.748,103.744,108.244,110.143,112.645,117.145,119.044,121.546,126.046,130.042,134.542,137.044,139.546,142.543,147.043,148.942,153.442,157.438,160.939,164.935,167.437,169.939,174.439,178.435,180.334,184.834,188.83,191.827,194.329,198.325,202.825,205.327,209.323,212.824,214.723,218.719,222.22,225.721,230.221,234.217,236.719,240.715,243.217,247.213,251.713,253.612,260.11,262.612,265.114,269.614,271.513,275.509,278.011,280.513,285.013,287.515,291.511,295.507,298.009" svgx:width="0.72,0.44,0.33,0.44,0.25,0.44,0.5,0.5,0.28,0.28,0.44,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.5,0.28,0.28,0.33,0.5,0.25,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.5,0.44,0.33,0.28,0.44,0.5,0.28,0.44,0.39,0.25,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">were applied to identify baseline variables associated with clinical </text>
   <text y="209.079" x="62.362,66.862,71.362,73.864,77.86,82.36,89.362,93.358,96.859,99.415,103.915,108.415,112.411,115.408,117.964,122.464,125.02,129.52,133.516,137.512,140.509,144.01,146.26,148.816,154.819,158.815,162.316,166.312,168.814,171.316,175.816,179.812,182.368,186.868,190.864,193.861,196.363,200.359,204.859,207.361,211.357,214.858,217.414,220.915,225.415,229.915,236.413,238.915,243.415,247.915,250.471,254.467,257.023,260.524,263.026,267.022,269.524,272.026,275.527,278.029,280.531,284.527,288.523,291.025,293.527,298.027" svgx:width="0.5,0.5,0.28,0.44,0.5,0.78,0.44,0.39,0.25,0.5,0.5,0.44,0.33,0.25,0.5,0.25,0.5,0.44,0.44,0.33,0.39,0.25,0.25,0.67,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.5,0.44,0.33,0.28,0.44,0.5,0.28,0.44,0.39,0.25,0.39,0.5,0.5,0.72,0.28,0.5,0.5,0.25,0.44,0.25,0.39,0.28,0.44,0.28,0.28,0.39,0.28,0.28,0.44,0.44,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">outcomes over 2 years. Baseline variables showing a statistically </text>
   <text y="220.077" x="62.362,65.863,68.365,72.865,77.365,79.867,82.864,85.366,89.362,93.358,97.858,100.36,102.88,106.876,110.377,113.878,118.378,122.374,124.876,128.872,131.374,133.876,138.376,142.876,145.396,151.894,154.396,156.898,161.398,163.918,168.418,172.918,175.42,179.416,183.916,190.918,194.914,198.415,200.935,203.437,207.937,210.457,214.453,216.973,221.473,225.973,228.475,232.975,236.971,239.968,242.47,246.466,248.968,252.964,255.484,262.486,266.986,271.486,275.482,277.984,280.504,287.002,290.998,293.995,297.991" svgx:width="0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.5,0.5,0.28,0.44,0.5,0.78,0.44,0.39,0.25,0.28,0.5,0.25,0.44,0.25,0.5,0.5,0.28,0.5,0.44,0.33,0.28,0.44,0.28,0.44,0.25,0.78,0.5,0.5,0.44,0.28,0.25,0.72,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">significant association with outcomes in a univariate model were </text>
   <text y="231.075" x="62.362,65.863,70.363,74.863,78.364,82.36,86.86,91.36,95.356,99.856,102.358,104.86,109.36,111.61,114.112,118.108,121.609,124.111,128.107,132.607,134.857,137.854,142.354,145.351,147.601,151.102,153.604,158.104,162.604,165.106,168.103,170.605,174.601,178.597,183.097,187.093,191.089,193.339,195.841,200.341,202.591,206.587,208.837,215.839,220.339,222.841,225.343,227.845,232.345,236.341,239.338,241.84,245.836,248.338,252.334,254.584,261.586,266.086,270.586,274.582,277.084" svgx:width="0.39,0.5,0.5,0.39,0.44,0.5,0.5,0.44,0.5,0.28,0.28,0.5,0.25,0.28,0.44,0.39,0.28,0.44,0.5,0.25,0.33,0.5,0.33,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.44,0.44,0.25,0.28,0.5,0.25,0.44,0.25,0.78,0.5,0.28,0.28,0.28,0.5,0.44,0.33,0.28,0.44,0.28,0.44,0.25,0.78,0.5,0.5,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">subsequently tested for significance in a multivariate model.</text>
   <text y="242.073" x="62.362,68.86,72.856,76.357,81.361,83.863,86.86,90.361,93.358" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="242.073" x="96.139,102.637,106.138,108.64,113.14,117.64,120.421,124.417,127.198,131.698,136.198,140.698,145.198,147.7,152.2,156.196,159.697,162.199,165.7,168.697,173.197,176.194,178.696,183.196,187.192,191.692,194.473,198.469,202.969,207.469,210.466,214.966,218.962,222.958,227.458,229.708,232.489,238.987,242.983,245.764,248.266,252.766,256.762,261.262,263.764,266.266,269.263,271.765,275.761,280.261,283.042,286.543,290.539,295.039" svgx:width="0.72,0.39,0.28,0.5,0.5,0.25,0.44,0.25,0.5,0.5,0.5,0.5,0.28,0.5,0.44,0.39,0.28,0.39,0.33,0.5,0.33,0.28,0.5,0.44,0.5,0.25,0.44,0.5,0.5,0.33,0.5,0.44,0.44,0.5,0.25,0.25,0.72,0.44,0.25,0.28,0.5,0.44,0.5,0.28,0.28,0.33,0.28,0.44,0.5,0.25,0.39,0.44,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Using a hypothesis-driven approach, we identified sev-</text>
   <text y="253.071" x="62.362,66.358,69.355,73.351,75.853,78.103,79.138,83.638,87.634,91.135,95.131,97.633,100.135,104.635,108.631,110.881,111.916,116.416,120.412,127.414,131.914,136.414,139.411,143.407,147.907,152.407,154.909,158.905,161.155,163.405,164.44,168.436,170.938,173.44,177.94,180.442,184.438,188.434,190.936,193.186,195.436,196.471,200.971,203.968,206.218,207.253,210.25,214.246,218.746,221.248,225.748,230.248,233.245,237.241,241.741,246.241,248.743,252.739,254.989,256.024,260.02,264.52,268.516,271.513,275.509,279.505,282.007,286.003,289.0,291.502,295.003" svgx:width="0.44,0.33,0.44,0.28,0.25,0.55,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.78,0.5,0.5,0.33,0.44,0.5,0.5,0.28,0.44,0.25,0.25,0.55,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.25,0.55,0.5,0.33,0.25,0.55,0.33,0.44,0.5,0.28,0.5,0.5,0.33,0.44,0.5,0.5,0.28,0.44,0.25,0.55,0.44,0.5,0.44,0.33,0.44,0.44,0.28,0.44,0.33,0.28,0.39,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">eral baseline demographic, clinical, or radiographic characteris-</text>
   <text y="264.069" x="62.362,64.864,67.366,71.362,74.863,77.113,80.812,84.313,86.815,90.811,93.313,95.815,99.316,101.818,104.32,108.316,112.312,114.814,117.316,121.816,124.066,127.765,131.266,133.768,138.268,142.768,145.27,148.267,150.769,154.765,158.761,163.261,165.763,168.265,172.765,175.015,178.714,182.71,186.211,189.712,194.212,198.208,200.71,204.706,207.208,211.204,215.704,217.954,221.653,228.151,230.653,233.155,237.655,239.905,243.604,246.601,250.597,253.099,257.095,261.595,265.096,269.092,271.342,275.041,279.037,283.537,288.037,290.539,295.039,298.036" svgx:width="0.28,0.28,0.44,0.39,0.25,0.55,0.39,0.28,0.44,0.28,0.28,0.39,0.28,0.28,0.44,0.44,0.28,0.28,0.5,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.55,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.25,0.55,0.44,0.5,0.5,0.28,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tics statistically significantly associated with relapse and/or </text>
   <text y="275.067" x="62.362,66.862,69.364,72.865,76.861,81.361,83.863,86.365,88.867,91.369,95.869,98.119,102.619,105.616,110.116,114.616,117.613,121.609,125.11,128.611,131.113,135.613,140.113,142.363,146.863,151.363,153.865,157.861,162.361,169.363,173.359,176.86" svgx:width="0.5,0.28,0.39,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.5,0.33,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.5,0.5,0.28,0.44,0.5,0.78,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">disability progression outcomes.</text>
   <text y="286.065" x="74.359,80.362,82.387,86.887,91.387,95.887,100.387,102.889,107.389,111.385,114.886,117.388,120.889,123.886,126.883,129.88,133.876,137.872,139.897,143.893,148.393,152.893,155.89,160.39,164.386,168.382,172.882,174.907,177.409,181.909,185.905,190.405,192.907,195.409,198.406,200.908,204.904,209.404,211.429,214.426,218.422,220.924,224.92,229.42,232.921,236.917,238.942,242.443,244.945,248.941,251.443,255.943,259.444,261.469,265.465,268.966,270.991,274.987,277.012,284.014,288.01,290.512,295.012,298.009" svgx:width="0.72,0.25,0.5,0.5,0.5,0.5,0.28,0.5,0.44,0.39,0.28,0.39,0.33,0.33,0.33,0.44,0.44,0.25,0.44,0.5,0.5,0.33,0.5,0.44,0.44,0.5,0.25,0.28,0.5,0.44,0.5,0.28,0.28,0.33,0.28,0.44,0.5,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.25,0.39,0.28,0.44,0.28,0.5,0.39,0.25,0.44,0.39,0.25,0.44,0.25,0.78,0.44,0.28,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">A hypothesis-free approach identified relapse status as a major </text>
   <text y="297.063" x="62.362,66.862,70.858,73.855,76.357,80.857,83.359,87.859,92.359,94.744,97.741,101.737,105.733,108.235,112.735,115.732,118.117,121.114,125.614,128.611,130.996,133.498,137.998,141.994,144.379,148.879,153.379,155.881,159.877,164.377,171.379,175.375,177.76,181.261,185.761,190.261,194.761,197.758,202.258,206.758,211.258,214.759,217.009,218.899,225.397,232.399,236.899,241.399,245.899,249.4,251.902,254.287,258.283,260.668,265.168,269.668,276.67,281.17,285.166,288.163,290.548,295.048,298.045" svgx:width="0.5,0.44,0.33,0.28,0.5,0.28,0.5,0.5,0.25,0.33,0.44,0.44,0.28,0.5,0.33,0.25,0.33,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.5,0.5,0.28,0.44,0.5,0.78,0.44,0.25,0.39,0.5,0.5,0.5,0.33,0.5,0.5,0.5,0.39,0.25,0.25,0.72,0.78,0.5,0.5,0.5,0.39,0.28,0.25,0.44,0.25,0.5,0.5,0.78,0.5,0.44,0.33,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">defining factor for the outcome subgroups. Amongst a number of </text>
   <text y="308.061" x="62.362,64.864,68.86,73.36,77.86,80.857,84.853,87.355,91.855,94.852,99.352,101.602,102.7,105.202,109.198,112.699,115.201,117.451,118.549,123.049,127.045,130.042,132.544,136.54,141.04,143.542,147.538,151.039,153.289,155.539,156.637,160.138,164.134,168.634,172.63,175.627,179.623,182.125,184.375,185.473,188.974,192.97,195.967,200.467,207.469,209.719,210.817,214.813,219.313,223.813,226.063,227.161,231.661,234.163,238.663,243.163,247.663,249.913,251.011,255.511,258.013,262.513,266.509,271.009,275.005,282.007,284.509,288.01,290.512,293.509,298.009" svgx:width="0.28,0.44,0.5,0.5,0.33,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.28,0.44,0.39,0.28,0.25,0.55,0.5,0.44,0.33,0.28,0.44,0.5,0.28,0.44,0.39,0.25,0.25,0.55,0.39,0.44,0.5,0.44,0.33,0.44,0.28,0.25,0.55,0.39,0.44,0.33,0.5,0.78,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.28,0.5,0.5,0.5,0.25,0.55,0.5,0.28,0.5,0.44,0.5,0.44,0.78,0.28,0.39,0.28,0.33,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">laboratory test variables, several serum and blood biochemistry </text>
   <text y="319.059" x="62.362,69.364,73.36,76.357,80.857,84.853,87.85,91.351,93.601,94.564,101.062,105.058,108.055,112.051,114.301,115.264,118.261,122.761,127.261,131.761,136.261,138.511,139.474,141.976,146.476,148.726,149.689,154.189,158.185,160.435,161.398,164.899,167.401,171.901,176.401,178.903,181.9,184.402,188.398,192.394,196.894,199.396,201.898,206.398,208.648,209.611,213.607,217.108,220.609,225.109,229.105,231.607,235.603,238.105,242.101,246.601,248.851,249.814,256.312,258.814,261.316,265.816,268.066,269.029,272.026,276.022,278.524,282.52,287.02,290.521,294.517,298.018" svgx:width="0.78,0.44,0.33,0.5,0.44,0.33,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.33,0.5,0.5,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.44,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.55,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">markers were found to be significantly associated with relapses </text>
   <text y="330.057" x="62.362,66.358,70.858,75.358,77.608,78.778,83.278,85.78,89.281,93.277,97.777,100.279,102.781,105.283,107.785,112.285,114.535,115.705,120.205,123.202,127.702,132.202,135.199,139.195,142.696,146.197,148.699,153.199,157.699,159.949,162.874,169.372,173.872,177.868,180.37,184.87,188.371,190.873,194.374,196.624,197.794,202.294,205.291,207.541,208.711,215.713,220.213,222.715,226.711,230.707,235.207,237.709,241.705,244.702,246.952,248.122,252.622,255.619,260.119,263.116,265.618,268.12,270.622,275.122,279.622,281.872,283.042,287.542,291.538,294.04,298.036" svgx:width="0.44,0.5,0.5,0.25,0.55,0.5,0.28,0.39,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.55,0.5,0.33,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.25,0.72,0.5,0.44,0.28,0.5,0.39,0.28,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.78,0.5,0.28,0.44,0.44,0.5,0.28,0.44,0.33,0.25,0.55,0.5,0.33,0.5,0.33,0.28,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and disability progression. Analysis of molecular profiling data </text>
   <text y="341.055" x="62.362,65.863,70.363,74.863,79.363,83.359,86.86,89.362,93.358,97.858,100.594,103.096,107.596,111.592,114.094,116.83,120.331,122.833,127.333,131.833,135.829,138.331,142.831,145.828,149.824,153.325,156.061,160.057,163.558,167.059,171.559,175.555,178.057,182.053,184.555,188.551,193.051,195.787,202.285,204.787,207.289,211.789,214.525,217.027,224.029,231.031,235.531,240.031,244.027,246.763,250.759,254.755,257.257,259.759,262.495,265.996,268.498,272.998,277.498,281.494,283.996,286.498,289.0,293.5,298.0" svgx:width="0.39,0.5,0.5,0.5,0.44,0.39,0.28,0.44,0.5,0.25,0.28,0.5,0.44,0.28,0.25,0.39,0.28,0.5,0.5,0.44,0.28,0.5,0.33,0.44,0.39,0.25,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.28,0.78,0.78,0.5,0.5,0.44,0.25,0.44,0.44,0.28,0.28,0.25,0.39,0.28,0.5,0.5,0.44,0.28,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">suggested that signatures associated with immune cell signalling </text>
   <text y="352.053" x="62.362,68.86,72.856,75.853,79.849,82.099,86.095,89.596,93.097,97.597,101.593,104.095,108.091,110.593,114.589,119.089,121.339,127.837,130.339,132.841,137.341,139.591,142.588,146.584,149.086,153.082,157.582,161.083,165.079,167.329,170.326,174.322,176.824,180.82,183.07,187.066,191.566,196.066,198.316,202.816,205.318,208.819,212.815,217.315,219.817,222.319,224.821,227.323,231.823,234.073,238.573,241.57,246.07,250.57,253.567,257.563,261.064,264.565,267.067,271.567,276.067" svgx:width="0.72,0.44,0.33,0.44,0.25,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.25,0.33,0.44,0.28,0.44,0.25,0.44,0.5,0.5,0.25,0.5,0.28,0.39,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.5,0.33,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">were associated with relapse rate and disability progression.</text>
   <text y="363.051" x="62.362,68.815,73.27,78.229,82.18,84.637,89.596,93.052,95.509,99.964,104.923,108.379,111.331" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="363.051" x="113.806,121.537,125.488,127.963,132.418,136.369,140.824,144.775,147.25,151.201,155.656,160.111,163.063,165.52,168.472,175.429,179.38,183.835,186.31,189.766,194.221,201.178,205.129,207.604,212.059,215.011,218.962,223.417,225.874,230.329,234.784,238.24,240.697,245.152,247.627,250.084,254.539,258.49,262.945,265.402,267.859,270.811,273.268,277.219,281.674,284.149,287.101,291.052,295.003" svgx:width="0.94,0.44,0.25,0.5,0.44,0.5,0.44,0.25,0.44,0.5,0.5,0.33,0.28,0.33,0.78,0.44,0.5,0.25,0.39,0.5,0.78,0.44,0.25,0.5,0.33,0.44,0.5,0.28,0.5,0.5,0.39,0.28,0.5,0.25,0.28,0.5,0.44,0.5,0.28,0.28,0.33,0.28,0.44,0.5,0.25,0.33,0.44,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">We have confirmed some previously identified fac-</text>
   <text y="374.049" x="62.362,64.819,69.274,72.226,75.682,77.932,79.066,83.017,86.473,89.929,94.384,98.335,100.792,104.743,107.2,111.151,115.606,117.856,118.99,125.443,127.9,130.357,134.812,137.062,138.196,142.651,145.108,148.564,152.515,156.466,159.922,163.873,166.123,167.248,171.199,175.15,177.607,180.064,184.519,186.976,189.433,193.888,196.138,197.272,201.727,204.679,206.929,208.063,212.518,215.47,219.925,224.38,227.332,231.283,234.739,238.195,240.652,245.107,249.562,251.812,252.946,256.402,260.857,264.808,269.263,271.513,272.638,276.589,280.045,282.295,283.429,287.38,291.835,295.786,298.036" svgx:width="0.28,0.5,0.33,0.39,0.25,0.55,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.55,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.33,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.39,0.5,0.44,0.5,0.25,0.55,0.44,0.39,0.25,0.55,0.44,0.5,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tors associated with disease activity or progression such as age, </text>
   <text y="385.047" x="62.362,66.817,69.769,73.72,76.672,80.128,82.585,87.04,91.495,95.95,98.2,98.893,101.845,105.796,108.253,112.204,116.659,120.115,124.066,127.522,129.727,131.977,132.67,137.125,141.076,144.532,148.483,150.94,153.397,157.852,161.803,164.053,164.746,170.2,176.653,181.612,186.571,188.821,189.514,193.465,197.92,202.375,204.625,205.318,211.771,216.226,221.257,223.507,224.2,226.657,230.608,234.064,236.521,240.976,245.431,248.887,251.092,253.342,254.035,257.986,262.441,266.896,269.146,269.839,272.296,276.751,279.001,279.694,283.645,288.1,292.555,295.012" svgx:width="0.5,0.33,0.44,0.33,0.39,0.28,0.5,0.5,0.5,0.25,0.55,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.39,0.25,0.25,0.55,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.61,0.72,0.56,0.56,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.72,0.5,0.56,0.25,0.55,0.28,0.44,0.39,0.28,0.5,0.5,0.39,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.5,0.5,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">pre-study relapses, baseline EDSS and Gd+ lesions, and in addi-</text>
   <text y="396.045" x="62.362,64.819,67.276,71.731,76.186,78.436,79.84,84.295,88.246,92.701,96.652,98.902,100.306,102.763,107.218,111.169,115.624,118.081,120.538,123.49,125.947,129.898,134.353,136.603,138.007,142.462,146.917,149.374,153.325,155.782,158.239,162.694,166.645,168.895,170.299,172.756,176.707,181.162,185.617,188.569,192.52,194.977,199.432,202.384,206.839,209.089,210.493,217.45,221.401,224.353,228.808,232.759,235.711,239.167,241.417,242.821,247.276,250.228,252.478,253.882,257.833,260.29,262.747,267.202,269.659,273.61,277.561,280.018,282.268,283.672,288.127,292.582,295.039" svgx:width="0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.44,0.5,0.44,0.25,0.55,0.28,0.5,0.44,0.5,0.28,0.28,0.33,0.28,0.44,0.5,0.25,0.55,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.28,0.44,0.5,0.5,0.33,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.78,0.44,0.33,0.5,0.44,0.33,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.5,0.5,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tion have identified putative laboratory markers of clinical out-</text>
   <text y="407.043" x="62.362,66.313,70.768,77.725,81.676,83.881,86.131,87.751,93.709,95.959,98.074,100.531,102.988,109.945,112.402,114.859,118.81,121.267,123.724,128.179,132.634,134.884,136.999,141.454,144.406,146.656,148.771,151.228,155.683,159.634,161.884,163.999,167.95,172.405,175.357,178.309,182.26,186.715,189.172,191.422,193.537,197.488,201.943,205.894,208.351,212.806,216.262,218.719,222.175,224.425,226.54,232.993,236.944,240.4,242.65,244.765,247.222,251.677,255.628,257.878,259.993,264.448,268.399,272.854,276.805,279.262,281.719,286.174,288.424,290.539,294.994,297.991" svgx:width="0.44,0.5,0.78,0.44,0.25,0.25,0.55,0.72,0.25,0.55,0.28,0.28,0.78,0.28,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.33,0.33,0.44,0.5,0.28,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.39,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.5,0.44,0.28,0.28,0.5,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">come. A limitation of the current analysis was the paucity of </text>
   <text y="418.041" x="62.362,65.314,69.265,71.722,75.673,80.128,83.584,87.535,90.397,94.348,98.803,103.258,106.12,110.575,113.032,116.488,120.439,124.894,127.351,129.808,132.265,134.722,139.177,142.039,146.494,149.446,153.901,158.356,161.308,165.259,168.715,172.171,174.628,179.083,183.538,186.4,190.351,194.806,198.757,203.212,205.669,209.125,211.987,214.444,218.899,221.761,224.218,228.673,232.624,235.486,239.437,243.892,248.347,250.804,254.755,259.21,261.667,264.529,268.984,271.936,274.798,278.749,281.611,284.068,290.521,294.976" svgx:width="0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.25,0.44,0.5,0.5,0.25,0.5,0.28,0.39,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.5,0.33,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.44,0.5,0.44,0.5,0.28,0.39,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.5,0.5,0.28,0.44,0.5,0.28,0.25,0.5,0.33,0.25,0.44,0.25,0.28,0.72,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">relapse and disability progression events in the context of a two-</text>
   <text y="429.039" x="62.362,66.817,70.768,74.719,77.671,79.921,81.271,85.222,87.679,90.136,94.591,97.048,100.999,104.95,107.407,109.657,111.007,113.464,116.416,118.873,122.824,125.281,127.486,129.736,130.924,136.378,140.833,144.784,147.034,148.384,152.335,156.79,159.742,162.694,166.645,171.1,173.557,175.807,177.157,181.108,185.563,189.514,191.971,196.426,199.882,202.339,205.795,208.045,209.395,215.848,218.305,220.762,223.219,225.469,226.819,231.274,235.225,237.475,238.825,242.776,247.231,251.686,255.637,260.092,264.547,268.498,272.953,275.203,276.553,279.01,283.465,285.715,287.065,289.522,293.977,297.973" svgx:width="0.5,0.44,0.44,0.33,0.25,0.55,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.28,0.33,0.28,0.44,0.28,0.25,0.25,0.55,0.61,0.5,0.44,0.25,0.55,0.44,0.5,0.33,0.33,0.44,0.5,0.28,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.39,0.25,0.55,0.72,0.28,0.28,0.28,0.25,0.55,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.44,0.5,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">year clinical trial. The current analysis will be expanded in the </text>
   <text y="440.037" x="62.362,65.314,69.769,72.226,76.681,79.633,83.584,86.293,92.746,95.203,97.66,102.115,104.824,107.281,111.736,115.687,118.396,122.347,126.802,131.257,133.714,136.171,138.628,143.083,147.538,150.247,154.702,157.654,160.363,164.818,168.769,171.226,175.177,177.886,180.838,183.79,188.245,195.202,197.911,202.366,204.823,208.774,212.725,216.676,221.131,225.586,228.295,231.751,236.206,240.661,243.118,247.069,251.02,253.477,256.933,259.642,262.594,265.546,270.001,276.958,279.667,284.122,286.579,291.034,294.985,297.982" svgx:width="0.33,0.5,0.28,0.5,0.33,0.44,0.25,0.72,0.28,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.5,0.5,0.28,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.5,0.44,0.28,0.44,0.25,0.33,0.33,0.5,0.78,0.25,0.5,0.28,0.44,0.44,0.44,0.5,0.5,0.25,0.39,0.5,0.5,0.28,0.44,0.44,0.28,0.39,0.25,0.33,0.33,0.5,0.78,0.25,0.5,0.28,0.5,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">future with the addition of data from placebo subjects from other </text>
   <text y="451.035" x="62.362,66.313,70.768,75.223,77.68,80.632,85.087,87.544,90.001,93.952,98.407,100.657,101.557,104.014,106.966,109.423,113.374,115.831,119.287,121.492,123.742,124.642,127.099,131.554,135.505,137.755,138.655,142.111,146.062,150.517,154.972,158.923,161.173,162.073,166.528,169.48,171.73,172.63,177.085,181.54,183.997,187.948,192.403,199.36,203.311,206.767,209.017,209.917,216.37,218.827,221.284,223.741,225.991,226.891,231.346,235.297,237.547,238.447,242.902,245.854,250.309,254.26,258.715,262.666,267.121,271.072,275.527,277.777,278.677,283.132,286.588,289.045,293.5,298.0" svgx:width="0.44,0.5,0.5,0.28,0.33,0.5,0.28,0.28,0.44,0.5,0.25,0.55,0.28,0.33,0.28,0.44,0.28,0.39,0.25,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.39,0.44,0.5,0.5,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.5,0.28,0.44,0.5,0.78,0.44,0.39,0.25,0.55,0.72,0.28,0.28,0.28,0.25,0.55,0.5,0.44,0.25,0.55,0.5,0.33,0.5,0.44,0.5,0.44,0.5,0.44,0.5,0.25,0.55,0.5,0.39,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">controlled trials, the scope of outcomes will be broadened using </text>
   <text y="462.033" x="62.362,66.313,70.768,75.223,77.68,80.137,82.594,87.049,91.504,95.455,97.912,100.162,102.412,106.363,108.82,111.277,115.732,118.189,122.14,126.091,128.548,130.798,133.048,136.999,141.454,145.909,148.159,150.409,158.365,164.323,167.275,169.525,171.775,176.23,180.181,182.638,186.589,188.794,191.044,193.132,198.586,202.537,204.994,207.451,211.906,215.857,218.314,220.771,225.226,229.681,231.931,234.181,238.636,241.588,243.838,246.088,248.545,253.0,256.951,260.407,264.358,266.608,268.858,271.81,274.267,278.722,283.177,285.634,290.089,294.544,298.045" svgx:width="0.44,0.5,0.5,0.28,0.28,0.28,0.5,0.5,0.44,0.28,0.25,0.55,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.89,0.67,0.33,0.25,0.55,0.5,0.44,0.28,0.44,0.25,0.25,0.55,0.72,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.39,0.44,0.25,0.55,0.33,0.28,0.5,0.5,0.28,0.5,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">additional clinical and MRI data. Validation of these findings </text>
   <text y="473.031" x="62.362,69.319,71.776,76.231,80.686,83.143,85.132,89.083,93.538,97.489,101.944,104.401,108.352,110.341,113.797,116.254,119.206,123.157,125.614,128.071,131.023,133.48,137.431,141.382,143.839,146.296,150.751,155.206,157.195,161.65,164.602,166.591,171.046,174.997,177.454,179.911,183.862,188.317,190.774,194.23,196.219,200.17,204.121,208.072,212.527,215.479,219.934,222.391,226.846,231.301,233.29,235.747,240.202,242.191,246.646,249.103,252.559,256.51,260.461,263.917,267.868,269.857,273.313,277.264,281.719,285.67,288.622,291.079,293.536,298.036" svgx:width="0.78,0.28,0.5,0.5,0.28,0.25,0.44,0.5,0.44,0.5,0.28,0.44,0.25,0.39,0.28,0.33,0.44,0.28,0.28,0.33,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.44,0.44,0.44,0.5,0.33,0.5,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.39,0.44,0.5,0.44,0.33,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">might enable stratification of patients according to disease severity </text>
   <text y="484.029" x="62.362,66.313,70.768,75.223,77.428,84.385,88.336,92.791,94.996,98.947,103.402,107.353,111.808,114.265,118.72,122.671,125.128,127.585,132.04,134.245,136.702,141.157,144.109,148.564,151.516,158.473,160.678,163.135,167.59,172.045,174.502,178.957,181.414,185.869,190.324,194.275,196.732,199.189,203.14,207.091,211.546,213.751,216.208,219.16,223.111,227.062,229.519,236.476,240.427,244.882,247.339,249.544,253.999,257.95,261.901,264.358,267.814,270.271,274.726,279.181,282.637" svgx:width="0.44,0.5,0.5,0.25,0.78,0.44,0.5,0.25,0.44,0.5,0.44,0.5,0.28,0.5,0.44,0.28,0.28,0.5,0.25,0.28,0.5,0.33,0.5,0.33,0.78,0.25,0.28,0.5,0.5,0.28,0.5,0.28,0.5,0.5,0.44,0.28,0.28,0.44,0.44,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.5,0.44,0.44,0.28,0.39,0.28,0.5,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and may eventually inform individualized treatment decisions.</text>
   <text y="511.029" x="62.362,67.861,72.361,76.861" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P762</text>
   <text y="522.027" x="62.362,67.861,72.361,75.862,79.363,81.865,86.869,89.371,93.367,95.617,100.621,104.617,109.117,113.617,118.621,123.121,126.622,129.619,132.121,136.117,138.367,141.364,145.864,149.86,152.857,157.357,161.353,164.854,167.104,170.101,174.601,178.597,180.847,185.347,187.849,191.35,196.354,200.854,203.356,205.606,208.603,213.607,218.611,222.607,225.604,228.106,232.606,237.61,239.86,244.36,247.357,250.354,254.35,258.346,260.596,265.096,270.1,273.097,275.599,279.595" svgx:width="0.61,0.5,0.39,0.39,0.28,0.56,0.28,0.44,0.25,0.56,0.44,0.5,0.5,0.56,0.5,0.39,0.33,0.28,0.44,0.25,0.33,0.5,0.44,0.33,0.5,0.44,0.39,0.25,0.33,0.5,0.44,0.25,0.5,0.28,0.39,0.56,0.5,0.28,0.25,0.33,0.56,0.56,0.44,0.33,0.28,0.5,0.56,0.25,0.5,0.33,0.33,0.44,0.44,0.25,0.5,0.56,0.33,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Possible prognostic factors for visual function after optic </text>
   <text y="533.025" x="62.362,67.366,71.362,76.366,80.362,82.864,85.861,88.363" svgx:width="0.56,0.44,0.56,0.44,0.28,0.33,0.28,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">neuritis</text>
   <text y="544.023" x="62.362,68.86,75.358,77.608,84.106,88.102,90.604" svgx:width="0.72,0.72,0.25,0.72,0.44,0.28,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">GH Dale</text>
   <text y="541.583" x="94.6" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="544.103" x="97.524,99.774,102.024,108.522,110.772,116.775,120.771,124.768,129.268,133.264,136.26,138.51,143.514,148.014,152.01,156.51,161.01,164.512,168.508" svgx:width="0.25,0.25,0.72,0.25,0.67,0.44,0.44,0.5,0.44,0.33,0.25,0.56,0.5,0.44,0.5,0.5,0.39,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, K Bacher Svendsen</text>
   <text y="541.583" x="173.007" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="544.103" x="175.932,178.182,180.432,185.93,188.18,194.184,198.18" svgx:width="0.25,0.25,0.61,0.25,0.67,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, T Bek</text>
   <text y="541.583" x="202.679" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="544.103" x="205.604,207.854,210.104,215.603,217.853,222.857,226.853,229.355,233.351,236.348,239.849,243.845" svgx:width="0.25,0.25,0.61,0.25,0.56,0.44,0.28,0.44,0.33,0.39,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, T Petersen</text>
   <text y="541.583" x="248.345" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="552.581" x="62.361" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="555.103" x="65.287,70.786,75.286,78.787,83.287,87.787,91.288,93.538,100.036,104.536,107.038,111.034,115.03,118.531,122.032,124.534,127.036,131.032,133.282,139.78,144.28,147.781,152.281,154.783,157.285,161.785,164.287,166.537,168.787,174.286,178.786,182.287,186.787,191.287,194.788,197.038,199.288,205.786,209.782,214.282,220.78,225.28,228.781" svgx:width="0.61,0.5,0.39,0.5,0.5,0.39,0.25,0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.72,0.5,0.39,0.5,0.28,0.28,0.5,0.28,0.25,0.25,0.61,0.5,0.39,0.5,0.5,0.39,0.25,0.25,0.72,0.44,0.5,0.72,0.5,0.39,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Aarhus University Hospital, Aarhus, Denmark</text>
   <text y="582.103" x="62.362,68.365,72.865,76.861,81.865,86.365,90.199,94.699,99.703,104.707,109.711,112.708" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="582.103" x="115.75,122.248,126.244,130.744,133.246,137.242,139.492,140.284,144.784,149.284,151.786,154.288,158.284,160.534,161.326,165.826,169.822,174.322,177.319,179.821,182.323,184.825,188.326,190.576,191.368,194.365,200.863,207.361,210.358,212.608,213.4,220.402,224.398,228.898,231.148,231.94,234.442,238.438,242.434,246.934,249.184,249.976,252.478,256.978,259.228,260.02,264.52,268.516,271.513,278.515,282.511,287.011,291.007,295.507,298.009" svgx:width="0.72,0.44,0.5,0.28,0.44,0.25,0.55,0.5,0.5,0.28,0.28,0.44,0.25,0.55,0.5,0.44,0.5,0.33,0.28,0.28,0.28,0.39,0.25,0.55,0.33,0.72,0.72,0.33,0.25,0.55,0.78,0.44,0.5,0.25,0.55,0.28,0.44,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.44,0.33,0.78,0.44,0.5,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Acute optic neuritis (ON) may lead to permanent </text>
   <text y="593.101" x="62.362,66.862,69.364,72.865,77.365,81.361,83.863,86.113,86.851,89.353,96.355,100.855,104.851,107.353,110.35,117.352,121.348,125.848,128.35,130.6,132.85,133.588,138.088,142.588,145.09,147.34,148.078,151.579,156.079,158.581,161.083,165.079,169.579,172.081,176.077,178.327,179.065,186.067,190.063,193.06,197.56,201.556,204.553,208.054,210.304,211.042,214.039,218.539,221.536,223.786,224.524,227.026,231.526,235.522,237.772,238.51,243.01,245.512,249.013,253.513,257.509,260.011,262.261,262.999,267.499,270.496,274.996,279.496,283.996,288.496,291.997,294.499,298.0" svgx:width="0.5,0.28,0.39,0.5,0.44,0.28,0.25,0.55,0.28,0.78,0.5,0.44,0.28,0.33,0.78,0.44,0.5,0.28,0.25,0.25,0.55,0.5,0.5,0.28,0.25,0.55,0.39,0.5,0.28,0.28,0.44,0.5,0.28,0.44,0.25,0.55,0.78,0.44,0.33,0.5,0.44,0.33,0.39,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.28,0.39,0.5,0.44,0.28,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.5,0.39,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">visual impairment, but suitable markers for the visual prognosis </text>
   <text y="604.099" x="62.362,66.358,69.355,73.351,75.601,78.103,82.099,86.095,90.595,93.097,97.597,102.097" svgx:width="0.44,0.33,0.44,0.25,0.28,0.44,0.44,0.5,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">are lacking.</text>
   <text y="615.097" x="62.362,69.364,74.368,77.365,81.361,85.357,88.354,90.856,95.356,99.352,102.853,105.85" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="615.097" x="108.37,113.239,117.739,120.259,122.761,127.261,131.761,135.757,139.258,141.76,144.262,148.762,152.758,155.26,159.256,161.776,168.274,172.774,176.77,179.272,183.772,187.768,190.765,193.285,197.281,201.781,206.281,208.783,211.78,215.776,219.277,221.779,224.299,227.8,231.796,236.296,239.797,242.299,244.801,247.303,251.803,254.305,256.807,260.722,262.972,265.492,271.495,275.491,279.991,282.493,286.489,288.991,293.491,297.991" svgx:width="0.61,0.5,0.25,0.28,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.44,0.28,0.44,0.25,0.72,0.5,0.44,0.28,0.5,0.44,0.33,0.25,0.44,0.5,0.5,0.28,0.33,0.44,0.39,0.28,0.25,0.39,0.44,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.25,0.67,0.44,0.5,0.28,0.44,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">To investigate whether contrast sensitivity, Rayleigh </text>
   <text y="626.095" x="62.362,69.364,73.36,75.862,79.858,84.358,86.608,90.46,94.456,98.956,103.456,110.458,114.454,116.956,121.456,124.957,128.953,133.453,137.953,142.453,144.703,148.555,153.055,156.052,158.302,162.154,165.151,169.147,171.649,174.151,178.651,182.647,185.149,187.399,191.251,195.751,199.747,202.744,207.244,211.24,213.49,217.342,220.339,222.841,227.341,231.337,234.334,236.584,240.436,242.938,246.934,251.434,255.43,258.427,260.677,264.529,267.031,271.531,274.033,278.029,282.529,287.029,291.025,294.526,298.027" svgx:width="0.78,0.44,0.28,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.78,0.44,0.28,0.5,0.39,0.44,0.5,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.33,0.44,0.28,0.28,0.5,0.44,0.28,0.25,0.55,0.5,0.44,0.33,0.5,0.44,0.25,0.55,0.33,0.28,0.5,0.44,0.33,0.25,0.55,0.28,0.44,0.5,0.44,0.33,0.25,0.55,0.28,0.5,0.28,0.44,0.5,0.5,0.44,0.39,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">match anomaloscopy or retinal nerve fiber layer thickness </text>
   <text y="637.093" x="62.362,65.359,71.362,77.86,82.864,87.535,93.034,96.031,98.281,99.64,103.636,107.632,112.132,114.382,115.741,120.241,124.237,126.487,127.855,132.355,135.856,139.852,144.352,146.602,147.961,151.957,155.458,157.708,159.076,163.576,166.573,171.073,175.573,180.073,184.573,188.074,190.576,193.078,197.074,199.324,200.683,203.68,207.676,211.672,214.174,218.674,221.671,225.172,227.422,228.781,231.778,236.278,239.275,241.525,242.893,247.393,249.895,253.396,257.896,261.892,264.394,266.644,268.003,271.0,275.5,280.0,283.996,286.498,289.0,293.5,298.0" svgx:width="0.33,0.67,0.72,0.56,0.61,0.61,0.33,0.25,0.55,0.44,0.44,0.5,0.25,0.55,0.5,0.44,0.25,0.55,0.5,0.39,0.44,0.5,0.25,0.55,0.44,0.39,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.5,0.39,0.28,0.28,0.44,0.25,0.55,0.33,0.44,0.44,0.28,0.5,0.33,0.39,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.5,0.28,0.39,0.5,0.44,0.28,0.25,0.55,0.33,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(RNFLT) can be used as prognostic factors for visual function </text>
   <text y="648.091" x="62.362,66.358,69.355,71.857,75.853,78.85,81.1,85.096,89.092,93.592,96.094,100.09,102.34,108.838,115.336" svgx:width="0.44,0.33,0.28,0.44,0.33,0.25,0.44,0.44,0.5,0.28,0.44,0.25,0.72,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">after acute ON.</text>
   <text y="659.089" x="62.362,70.858,74.854,77.851,82.855,87.355,92.359,95.86,98.857" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="659.089" x="101.719,106.588,113.086,117.082,121.582,124.084,128.584,131.581,136.081,138.583,143.083,147.079,149.941,154.441,158.437,160.939,163.441,167.437,171.937,174.439,177.94,180.802,183.799,188.299,192.799,195.661,198.658,202.654,209.656,213.652,216.154,220.15,222.4,225.262,229.429,233.929,236.791,243.793,247.789,250.291,254.287,257.284,260.146,266.644,269.146,271.648,276.148,279.01,283.006,287.002,291.502,294.004,298.0" svgx:width="0.61,0.72,0.44,0.5,0.28,0.5,0.33,0.5,0.28,0.5,0.44,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.33,0.5,0.5,0.25,0.33,0.44,0.78,0.44,0.28,0.44,0.25,0.25,0.5,0.5,0.25,0.78,0.44,0.28,0.44,0.33,0.25,0.72,0.28,0.28,0.5,0.25,0.44,0.44,0.5,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Twenty-nine patients (18 female, 11 male) with acute </text>
   <text y="670.087" x="62.362,68.86,75.358,77.608,78.715,85.213,89.209,92.206,96.202,98.452,99.559,103.555,108.055,112.051,119.053,121.555,126.055,130.051,134.551,136.801,139.051,140.158,146.161,150.157,153.658,156.16,158.41,159.517,163.513,168.013,171.01,174.007,178.003,181.999,184.501,188.497,192.997,195.247,196.354,200.854,203.356,206.857,211.357,215.353,217.855,220.105,221.212,225.208,229.204,233.704,236.206,238.708,243.208,245.458,246.565,249.562,255.565,261.568,266.905,273.403,276.4,278.65,280.9,282.007,286.003,290.503,295.003" svgx:width="0.72,0.72,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.44,0.5,0.44,0.78,0.28,0.5,0.44,0.5,0.25,0.25,0.55,0.67,0.44,0.39,0.28,0.25,0.55,0.44,0.5,0.33,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.28,0.39,0.5,0.44,0.28,0.25,0.55,0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.55,0.33,0.67,0.67,0.72,0.72,0.33,0.25,0.25,0.55,0.44,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ON were examined. Best corrected visual acuity (BCVA), con-</text>
   <text y="681.085" x="62.362,64.864,67.861,71.857,75.358,77.86,80.038,83.539,87.535,92.035,95.536,98.038,100.54,103.042,107.542,110.044,112.546,116.461,118.711,120.889,126.892,130.888,135.388,137.89,141.886,144.388,148.888,153.388,155.566,162.568,166.564,169.066,173.062,177.562,179.74,183.736,188.236,192.736,199.738,203.734,206.236,210.736,214.237,218.233,222.733,227.233,231.733,233.911,237.907,242.407,246.907,249.085,255.088,261.586,266.59,271.261,276.094,278.344,280.522,287.02,291.016,294.013,298.009" svgx:width="0.28,0.33,0.44,0.39,0.28,0.25,0.39,0.44,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.25,0.67,0.44,0.5,0.28,0.44,0.28,0.5,0.5,0.25,0.78,0.44,0.28,0.44,0.5,0.25,0.44,0.5,0.5,0.78,0.44,0.28,0.5,0.39,0.44,0.5,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.67,0.72,0.56,0.61,0.61,0.25,0.25,0.72,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">trast sensitivity, Rayleigh match anomaloscopy and RNFLT, were </text>
   <text y="692.083" x="62.362,66.862,70.858,73.36,77.356,80.353,87.355,89.857,94.357,98.353,102.853,105.103,106.318,110.314,112.816,115.066,116.281,118.783,123.283,127.279,129.529,130.744,133.246,135.748,142.75,146.746,148.996,150.211,154.711,157.708,159.958,161.173,165.673,168.175,172.171,176.671,181.171,185.671,189.172,191.674,195.175,197.425,198.64,202.636,207.136,211.636,213.886,215.101,219.097,222.094,224.596,228.592,231.589,233.839,235.054,239.554,241.804,243.019,250.021,254.521,259.021,261.523,266.023,269.524,271.774,274.024,275.077,281.035,283.537,287.038,291.538,295.534,298.036" svgx:width="0.5,0.44,0.28,0.44,0.33,0.78,0.28,0.5,0.44,0.5,0.25,0.55,0.44,0.28,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.28,0.28,0.78,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.28,0.44,0.5,0.5,0.5,0.39,0.28,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.33,0.28,0.44,0.33,0.25,0.55,0.5,0.25,0.55,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.25,0.55,0.72,0.28,0.39,0.5,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">determined at the time of diagnosis and after 6 months. Visual </text>
   <text y="703.081" x="62.362,65.359,69.859,74.359,78.355,80.857,83.359,87.859,92.359,94.609,101.107,105.103,108.604,110.854,115.354,119.35,122.347,124.849,129.349,133.345,137.845,140.095,144.595,149.095,151.345,157.348,163.351,168.688,175.186" svgx:width="0.33,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.5,0.44,0.33,0.28,0.5,0.44,0.5,0.25,0.5,0.5,0.25,0.67,0.67,0.72,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">function was defined by BCVA.</text>
   <text y="714.079" x="74.359,79.363,83.863,86.86,88.894,92.89,96.886,100.882,105.382,107.416,111.916,116.416,119.917,123.418,125.92,130.42,132.922,136.918,138.952,143.452,146.449,150.949,155.449,159.949,164.449,167.95,170.452,172.954,176.95,178.984,185.986,189.982,192.979,197.479,201.475,204.112,206.362,208.396,210.898,215.398,219.394,221.428,225.928,229.924,232.426,234.928,238.924,243.424,245.926,249.427,251.461,257.959,261.955,264.952,268.948,270.982,275.482,277.984,282.484,284.986,289.486,293.482,297.982" svgx:width="0.56,0.5,0.33,0.25,0.44,0.44,0.44,0.5,0.25,0.5,0.5,0.39,0.39,0.28,0.5,0.28,0.44,0.25,0.5,0.33,0.5,0.5,0.5,0.5,0.39,0.28,0.28,0.44,0.25,0.78,0.44,0.33,0.5,0.44,0.33,0.25,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.5,0.28,0.5,0.28,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">For each possible prognostic marker, the patients were divided </text>
   <text y="725.077" x="62.362,64.864,69.364,71.866,76.366,78.805,82.801,85.24,92.242,96.742,101.242,105.238,108.235,112.231,114.733,118.729,121.231,125.731,128.17,130.672,135.172,137.611,141.112,145.108,149.608,153.604,156.601,160.597,163.099,167.599,170.038,174.034,176.869,179.866,183.862,187.858,190.36,194.356,198.856,201.295,204.292,212.293,217.297,223.795,226.792,229.231,233.731,236.728,241.228,245.728,250.228,252.667,256.663,261.163,265.663,268.102,272.098,274.537,281.539,284.041,286.543,291.043,293.545,298.045" svgx:width="0.28,0.5,0.28,0.5,0.25,0.44,0.25,0.78,0.5,0.5,0.44,0.33,0.44,0.28,0.44,0.28,0.5,0.25,0.28,0.5,0.25,0.39,0.44,0.5,0.44,0.33,0.44,0.28,0.5,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.33,0.89,0.56,0.72,0.33,0.25,0.5,0.33,0.5,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.44,0.25,0.78,0.28,0.28,0.5,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">into a moderately to severely affected (MSA) group and a mildly </text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M310.020 479.300 L354.270 479.300 "/>
  <g begin="text">
   <text y="77.103" x="310.016,314.012,316.847,319.844,323.84,327.836,330.338,334.334,338.834,341.399,343.901,348.401,350.966,355.466,359.966,362.963,369.965,373.961,376.463,379.028,382.025,390.026,396.524,403.022,406.019,408.584,413.084,416.081,420.581,425.081,429.581,431.831,434.396,438.896,442.892,447.392,451.388,455.888,460.388,462.89,467.39,471.89,474.455,478.955,483.455,486.02,488.522,493.022,497.018,499.583,504.083,508.079,511.58,515.576,518.078,520.58,525.08,529.076,531.641,536.141,540.137,542.639" svgx:width="0.44,0.33,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.5,0.33,0.78,0.44,0.28,0.25,0.33,0.89,0.72,0.72,0.33,0.25,0.5,0.33,0.5,0.5,0.5,0.25,0.25,0.5,0.44,0.5,0.44,0.5,0.5,0.28,0.5,0.5,0.25,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.5,0.44,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">affected to normal (MAN) group, depending on the baseline val-</text>
   <text y="88.101" x="310.016,314.516,318.512,322.013,324.263,326.666,332.165,336.665,340.661,343.226,351.227,356.231,362.729,365.726,370.226,373.223,377.723,382.223,386.723,389.288,395.786,399.782,403.283,405.848,410.348,414.344,417.341,419.843,424.343,428.339,432.839,435.404,439.904,444.404,446.969,449.471,453.971,458.471,461.036,465.032,469.532,474.032,476.534,479.531,483.527,487.028,489.53,492.095,495.596,499.592,504.092,507.593,510.095,512.597,515.099,519.599,522.101,524.603,529.103,531.668,536.168,540.164,542.666" svgx:width="0.5,0.44,0.39,0.25,0.25,0.61,0.5,0.44,0.25,0.89,0.56,0.72,0.33,0.5,0.33,0.5,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.5,0.44,0.33,0.28,0.5,0.44,0.5,0.25,0.5,0.5,0.25,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.28,0.33,0.44,0.39,0.28,0.25,0.39,0.44,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.5,0.44,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ues. The MSA-group was defined by log contrast sensitivity val-</text>
   <text y="99.099" x="310.016,314.516,318.512,322.013,324.479,328.979,332.975,335.477,339.977,346.475,348.941,353.441,355.691,360.191,364.691,366.941,369.407,375.41,379.406,383.906,386.408,390.404,392.906,397.406,401.906,404.372,411.374,415.37,417.872,421.868,426.368,428.834,432.335,436.331,438.833,441.335,443.837,448.337,452.837,455.303,458.3,462.296,466.796,471.296,475.292,477.758,480.755,485.759,491.762,494.759,497.225,501.725,505.721,508.223,512.723,516.719,520.22,522.686,527.186,529.688,534.188,538.688,542.684,545.681" svgx:width="0.5,0.44,0.39,0.25,0.5,0.44,0.28,0.5,0.72,0.25,0.5,0.25,0.5,0.5,0.25,0.25,0.67,0.44,0.5,0.28,0.44,0.28,0.5,0.5,0.25,0.78,0.44,0.28,0.44,0.5,0.25,0.39,0.44,0.28,0.28,0.28,0.5,0.5,0.25,0.33,0.44,0.5,0.5,0.44,0.25,0.33,0.56,0.67,0.33,0.25,0.5,0.44,0.28,0.5,0.44,0.39,0.25,0.5,0.28,0.5,0.5,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ues below 1,35, Rayleigh match setting range (SR) values higher </text>
   <text y="110.097" x="310.016,312.518,317.018,321.014,325.514,327.764,329.42,333.92,338.42,340.67,342.326,346.322,350.822,355.322,357.572,359.228,361.73,366.23,370.226,372.476,374.132,378.632,383.132,387.128,390.125,394.121,396.623,399.125,401.375,403.031,409.034,415.532,420.536,425.207,430.544,432.794,434.45,438.446,440.948,444.944,448.445,451.946,454.448,457.445,459.947,463.943,468.443,470.693,472.349,476.345,479.846,482.096,483.752,487.748,492.248,496.748,499.745,504.245,508.241,511.238,513.74,516.242,520.742,524.738,528.734,530.984,532.64,536.636,541.136,545.636" svgx:width="0.28,0.5,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.5,0.44,0.33,0.44,0.28,0.28,0.25,0.55,0.67,0.72,0.56,0.61,0.61,0.25,0.55,0.44,0.28,0.44,0.39,0.39,0.28,0.33,0.28,0.44,0.5,0.25,0.55,0.44,0.39,0.25,0.55,0.44,0.5,0.5,0.33,0.5,0.44,0.33,0.28,0.28,0.5,0.44,0.44,0.25,0.55,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">than 16 and the overall RNFLT classified as “borderline” and </text>
   <text y="121.095" x="310.016,314.012,318.512,323.012,325.514,329.015,331.517,336.017,340.013,342.263,346.763,351.263,354.26,361.262,365.258,367.76,370.01,372.512,375.014,382.016,384.518,387.02,390.521,394.517" svgx:width="0.44,0.5,0.5,0.28,0.39,0.28,0.5,0.44,0.25,0.5,0.5,0.33,0.78,0.44,0.28,0.25,0.28,0.28,0.78,0.28,0.28,0.39,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">“outside normal limits”.</text>
   <text y="132.093" x="322.013,327.017,331.517,334.514,336.998,340.499,343.001,346.997,349.499,352.001,355.502,358.004,360.506,364.502,368.498,371.0,373.484,377.48,381.98,385.976,388.478,392.978,396.479,398.981,402.482,404.732,407.216,409.718,414.218,418.214,420.698,423.2,427.7,432.2,440.201,446.699,452.702,455.186,459.686,462.683,465.167,471.17,477.173,482.51,488.513,490.997,497.495,501.491,504.992,507.476,511.976,515.477,519.473,523.973,526.223,528.707,535.205,539.201,541.703,545.699" svgx:width="0.56,0.5,0.33,0.25,0.39,0.28,0.44,0.28,0.28,0.39,0.28,0.28,0.44,0.44,0.28,0.25,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.39,0.25,0.25,0.28,0.5,0.44,0.25,0.28,0.5,0.5,0.89,0.72,0.67,0.25,0.5,0.33,0.25,0.67,0.67,0.72,0.72,0.25,0.72,0.44,0.39,0.25,0.5,0.39,0.44,0.5,0.25,0.25,0.72,0.44,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">For statistical analysis, the logMAR of BCVA was used. Data </text>
   <text y="143.091" x="310.016,316.514,320.51,324.011,326.261,330.257,334.757,338.753,341.255,345.755,349.751,353.747,358.247,360.497,366.995,369.497,371.999,376.499,378.749,383.249,387.749,392.249,395.246,399.746,403.742,406.739,410.735,417.737,421.733,424.235,427.232,429.734,433.73,435.98,438.482,442.478,445.979,448.481,451.982" svgx:width="0.72,0.44,0.39,0.25,0.44,0.5,0.44,0.28,0.5,0.44,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.5,0.5,0.5,0.33,0.5,0.44,0.33,0.44,0.78,0.44,0.28,0.33,0.28,0.44,0.25,0.28,0.44,0.39,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">was analyzed with non-parametric tests.</text>
   <text y="154.089" x="310.016,316.559,320.6,324.146,329.195,331.742,334.784,338.33,341.372" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="154.089" x="343.586,348.635,353.18,356.222,358.436,362.981,367.526,370.073,374.618,376.832,380.873,385.418,389.963,392.51,395.552,399.593,403.139,405.686,407.9,411.446,415.487,420.032,423.578,426.125,428.672,431.219,435.764,438.311,440.858,445.403,447.617,451.658,456.203,460.748,462.962,469.01,473.051,477.596,480.143,484.184,486.731,491.276,495.821,498.035,505.082,509.123,511.67,515.711,520.256,522.47,526.511,531.056,535.601,542.648" svgx:width="0.56,0.5,0.33,0.25,0.5,0.5,0.28,0.5,0.25,0.44,0.5,0.5,0.28,0.33,0.44,0.39,0.28,0.25,0.39,0.44,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.44,0.5,0.5,0.25,0.67,0.44,0.5,0.28,0.44,0.28,0.5,0.5,0.25,0.78,0.44,0.28,0.44,0.5,0.25,0.44,0.5,0.5,0.78,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">For both contrast sensitivity and Rayleigh match anom-</text>
   <text y="165.087" x="310.016,314.057,316.604,321.149,324.695,328.736,333.281,337.826,341.786,344.081,346.187,348.734,353.279,357.32,359.426,367.472,372.521,379.064,382.106,386.651,389.693,394.238,398.783,403.328,405.434,409.979,414.02,418.565,420.671,424.217,426.764,431.309,435.854,438.401,441.443,443.99,448.031,452.072,456.617,459.164,461.711,466.256,468.362,474.905,479.45,482.492,486.038,490.079,492.185,498.233,504.281,509.663,515.711,517.817,521.858,524.405,526.511,531.056,535.097,538.643,542.684" svgx:width="0.44,0.28,0.5,0.39,0.44,0.5,0.5,0.5,0.25,0.25,0.28,0.5,0.44,0.25,0.89,0.56,0.72,0.33,0.5,0.33,0.5,0.5,0.5,0.25,0.5,0.44,0.5,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.72,0.5,0.33,0.39,0.44,0.25,0.67,0.67,0.72,0.72,0.25,0.44,0.28,0.25,0.5,0.44,0.39,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">aloscopy, the MSA-group had significantly worse BCVA at base-</text>
   <text y="176.085" x="310.016,312.563,315.11,319.655,323.696,325.991,328.241,333.047,337.088,341.633,348.68,353.225,357.266,360.308,364.349,368.894,371.144,375.95,378.497,383.042,385.292,390.098,392.645,397.19,401.231,403.481,408.287,416.333,422.876,429.419,432.461,437.006,440.048,444.593,449.138,453.683,455.933,460.739,463.781,466.328,470.873,475.418,477.668,482.474,486.515,491.06,495.605,498.152,501.194,505.235,508.781,511.328,513.578,518.384,522.929,525.971,530.516,534.557,537.104,541.649,545.645" svgx:width="0.28,0.28,0.5,0.44,0.25,0.25,0.55,0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.89,0.72,0.72,0.33,0.5,0.33,0.5,0.5,0.5,0.25,0.55,0.33,0.28,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.28,0.33,0.44,0.39,0.28,0.25,0.55,0.5,0.33,0.5,0.44,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">line, compared to the MAN-group (log contrast p-value </text>
   <text y="187.083" x="310.016,313.058,317.603,320.645,325.766,330.311,332.606,337.151,341.696,346.241,350.786,353.081,355.574,360.623,366.671,369.164,373.709,378.83,383.375,385.67,390.215,394.76,399.305,403.85,406.892,409.187,411.518,417.062,421.607,425.648,428.69,432.731,435.224,441.767,445.808,449.354,451.847,455.888,458.381,461.927,464.474,469.019,473.564,476.111,479.153,481.7,485.741,489.782,494.327,496.874,499.367,503.912,506.459,509.339,512.381,516.422,519.464,523.505,528.05,532.091,536.132,538.625,541.172,545.672" svgx:width="0.33,0.5,0.33,0.56,0.5,0.25,0.5,0.5,0.5,0.5,0.25,0.25,0.56,0.67,0.25,0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.61,0.5,0.44,0.33,0.44,0.25,0.72,0.44,0.39,0.25,0.44,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.44,0.44,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(p)=0,0003, SR p=0,0001). There was a significant difference in </text>
   <text y="198.081" x="310.016,312.563,317.108,321.149,322.895,325.442,332.489,337.034,340.076,344.621,349.166,353.207,360.254,364.295,368.84,371.387,373.133,377.678,380.72,382.466,388.514,394.562,399.944,405.992,407.738,412.283,416.828,419.87,422.417,426.962,431.507,433.253,435.8,440.345,444.386,446.132,450.677,455.222,458.768,462.809,465.851,470.396,474.437,476.984,479.531,484.076,488.621,490.367,494.912,498.953,501.995,504.542,509.087,513.632,515.378,519.923,523.964,526.511,533.054,537.095,541.136,545.636" svgx:width="0.28,0.5,0.44,0.25,0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.78,0.44,0.5,0.28,0.25,0.5,0.33,0.25,0.67,0.67,0.72,0.72,0.25,0.5,0.5,0.33,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.5,0.39,0.44,0.33,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.44,0.33,0.28,0.5,0.5,0.25,0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">the improvement of BCVA during the observation period between </text>
   <text y="209.079" x="310.016,312.563,317.108,321.149,323.399,325.748,328.295,334.838,339.383,341.633,343.982,348.527,351.569,356.114,360.659,365.204,368.75,371.045,373.295,375.644,378.686,383.231,386.273,388.523,390.872,395.417,399.962,402.509,407.054,409.304,411.653,415.694,420.239,424.784,427.331,430.373,434.414,437.96,440.507,442.757,445.106,448.652,452.693,457.238,460.784,463.331,465.878,468.425,472.97,475.517,478.064,482.609,484.859,487.208,490.25,494.795,499.916,504.461,506.756,511.301,515.846,520.391,524.936,527.978,530.228,532.577,536.618,541.163,545.663" svgx:width="0.28,0.5,0.44,0.25,0.55,0.28,0.72,0.5,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.39,0.25,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.5,0.5,0.28,0.5,0.25,0.55,0.44,0.5,0.5,0.28,0.33,0.44,0.39,0.28,0.25,0.55,0.39,0.44,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.55,0.33,0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.5,0.33,0.25,0.55,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">the two groups, for both contrast sensitivity (p=0,0008) and </text>
   <text y="220.077" x="310.016,316.064,320.105,324.65,327.197,331.238,333.785,338.33,342.875,345.359,352.406,356.447,358.994,363.035,367.58,370.064,373.106,377.651,382.772,387.317,389.612,394.157,398.702,403.247,407.792,410.834,413.129,415.451,420.995,425.54,429.581,432.065,436.61,439.652,443.693,447.734,450.281,454.322,457.868,460.415,462.899,465.446,472.493,477.038,480.08,484.625,489.17,493.211,500.258,504.299,508.844,511.391,513.875,518.42,522.461,526.502,531.047,534.089,537.131,541.172,545.672" svgx:width="0.67,0.44,0.5,0.28,0.44,0.28,0.5,0.5,0.25,0.78,0.44,0.28,0.44,0.5,0.25,0.33,0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.61,0.5,0.44,0.25,0.5,0.33,0.44,0.44,0.28,0.44,0.39,0.28,0.25,0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.78,0.44,0.5,0.28,0.25,0.5,0.44,0.44,0.5,0.33,0.33,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Rayleigh match (p=0,0003). The greatest improvement occurred </text>
   <text y="231.075" x="310.016,312.563,317.108,319.727,322.274,326.819,330.86,333.479,341.525,346.574,353.117,356.159,360.704,363.746,368.291,372.836,377.381,379.676,381.8,388.343,390.89,393.509,398.054,400.673,407.72,412.265,416.81,419.357,423.902,427.448,429.743,432.362,434.909,439.454,443.495,446.537,450.578,453.197,459.74,463.781,467.327,469.946,474.491,479.036,481.655,485.201,487.748,492.293,496.838,499.385,502.427,504.974,509.015,513.056,517.601,520.148,522.767,527.312,529.859,532.739,535.781,539.822,542.675" svgx:width="0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.89,0.56,0.72,0.33,0.5,0.33,0.5,0.5,0.5,0.25,0.25,0.72,0.28,0.25,0.5,0.25,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.25,0.28,0.5,0.44,0.33,0.44,0.25,0.72,0.44,0.39,0.25,0.5,0.5,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">in the MSA-group. At 6 months, there was no significant differ-</text>
   <text y="242.073" x="310.016,314.057,318.602,322.643,326.684,329.312,331.859,336.404,339.032,345.08,351.128,356.51,362.558,365.186,371.729,376.274,380.315,384.86,387.488,390.035,394.58,399.125,403.67,406.217,410.762,415.307,417.935,421.976,424.523,427.151,431.192,435.737,440.282,442.829,445.871,449.912,453.458,456.005,458.633,462.179,466.22,470.765,474.311,476.858,479.405,481.952,486.497,489.044,491.591,496.136,498.764,501.806,509.852,514.901,521.444,524.486,529.031,532.073,536.618,541.163,545.663" svgx:width="0.44,0.5,0.44,0.44,0.25,0.28,0.5,0.25,0.67,0.67,0.72,0.72,0.25,0.72,0.5,0.44,0.5,0.25,0.28,0.5,0.5,0.5,0.28,0.5,0.5,0.25,0.44,0.28,0.25,0.44,0.5,0.5,0.28,0.33,0.44,0.39,0.28,0.25,0.39,0.44,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.33,0.89,0.56,0.72,0.33,0.5,0.33,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ence in BCVA when looking at contrast sensitivity (MSA-group </text>
   <text y="253.071" x="310.016,317.063,321.104,325.145,329.69,331.94,334.46,337.502,342.047,344.342,348.887,353.432,357.977,360.272,362.522,365.042,371.585,379.631,386.174,389.216,393.761,396.803,401.348,405.893,410.438,412.688,415.208,422.255,426.296,430.337,434.882,437.132,439.652,442.694,447.239,449.534,454.079,458.624,460.919,463.169,465.689,470.234,475.355,479.9,482.195,486.74,491.285,495.83,500.375,503.417,505.712,507.962,510.482,517.025,521.57,528.113,532.154,536.699,540.74,543.422,545.672" svgx:width="0.78,0.44,0.44,0.5,0.25,0.55,0.33,0.5,0.25,0.5,0.5,0.5,0.25,0.25,0.55,0.72,0.89,0.72,0.33,0.5,0.33,0.5,0.5,0.5,0.25,0.55,0.78,0.44,0.44,0.5,0.25,0.55,0.33,0.5,0.25,0.5,0.5,0.25,0.25,0.55,0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.55,0.72,0.5,0.72,0.44,0.5,0.44,0.33,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">mean -0,059, NMA-group mean -0,17, p=0,0948). However, </text>
   <text y="264.069" x="310.016,316.064,322.112,327.494,333.542,335.738,342.281,346.322,349.868,352.064,355.61,358.157,360.704,363.251,365.798,367.994,371.54,374.087,378.632,383.177,385.724,388.766,391.313,395.354,399.395,403.94,406.487,409.034,413.579,415.775,422.318,426.863,429.905,433.451,437.492,439.688,442.235,446.78,448.976,451.523,456.068,460.109,462.305,466.85,469.892,474.437,478.982,483.527,485.723,492.266,494.813,497.36,501.905,504.101,510.644,515.189,518.231,521.777,524.324,526.52,531.065,535.106,538.652,542.693" svgx:width="0.67,0.67,0.72,0.72,0.25,0.72,0.44,0.39,0.25,0.39,0.28,0.28,0.28,0.28,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.72,0.5,0.33,0.39,0.44,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.33,0.5,0.5,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.72,0.5,0.33,0.39,0.28,0.25,0.5,0.44,0.39,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">BCVA was still significantly worse in the group with worst base-</text>
   <text y="275.067" x="310.016,312.563,315.11,319.655,323.696,325.946,327.422,332.471,338.519,340.814,343.064,344.54,348.581,353.126,360.173,364.718,368.759,371.801,375.842,380.387,382.637,384.113,386.66,391.205,393.455,394.931,397.478,402.023,406.064,408.314,409.79,417.836,424.379,430.922,433.964,438.509,441.551,446.096,450.641,455.186,457.436,458.912,461.954,469.001,473.042,477.083,481.628,483.878,485.354,488.396,492.941,495.236,499.781,504.326,508.871,511.121,512.597,517.142,520.688,522.938,524.414,527.456,532.001,534.296,538.841,543.386,545.636" svgx:width="0.28,0.28,0.5,0.44,0.25,0.55,0.56,0.67,0.25,0.25,0.55,0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.89,0.72,0.72,0.33,0.5,0.33,0.5,0.5,0.5,0.25,0.55,0.33,0.78,0.44,0.44,0.5,0.25,0.55,0.33,0.5,0.25,0.5,0.5,0.5,0.25,0.55,0.5,0.39,0.25,0.55,0.33,0.5,0.25,0.5,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">line SR, compared to the MAN-group (mean -0,037 vs -0,18, </text>
   <text y="286.065" x="310.016,314.561,319.682,324.227,326.522,331.067,335.612,340.157,343.199" svgx:width="0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">p=0,012).</text>
   <text y="297.063" x="322.013,327.017,331.517,334.514,336.764,339.041,345.044,351.542,356.546,361.217,366.05,368.3,370.55,372.827,375.329,379.829,383.825,386.822,390.818,393.068,395.345,401.843,405.839,409.34,411.59,413.867,418.367,422.867,425.117,427.394,430.895,433.397,437.897,442.397,444.899,447.896,450.398,454.394,458.39,462.89,465.392,467.642,469.919,474.419,476.921,479.756,482.753,486.749,489.746,493.742,498.242,502.238,506.234,508.484,510.761,513.263,517.763,520.013,522.29,528.293,534.296,539.633,545.636" svgx:width="0.56,0.5,0.33,0.25,0.55,0.67,0.72,0.56,0.61,0.61,0.25,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.5,0.5,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25,0.55,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.44,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.67,0.67,0.72,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">For RNFLT, there was no significant difference in BCVA </text>
   <text y="308.061" x="310.016,314.516,318.512,321.014,327.512,331.508,335.504,340.004,342.254,343.262,345.764,350.264,354.26,356.51,357.518,360.02,366.518,371.018,373.268,374.276,378.776,381.773,386.273,390.773,395.273,398.774,401.024,403.274,404.282,408.782,412.778,415.28,417.782,422.282,426.278,429.275,431.525,432.533,436.529,439.031,441.281,442.289,446.789,450.785,454.286,458.282,460.784,463.286,467.786,471.782,474.032,475.04,478.037,482.537,484.787,485.795,490.871,493.121,494.129,498.629,500.879,505.379,509.879,512.876,515.126,516.134,520.634,525.134,528.131,530.381,531.389,535.385,537.887,540.137,541.145,545.645" svgx:width="0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.28,0.72,0.5,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.39,0.25,0.25,0.55,0.5,0.44,0.28,0.28,0.5,0.44,0.33,0.25,0.55,0.44,0.28,0.25,0.55,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.33,0.5,0.25,0.55,0.56,0.25,0.55,0.5,0.25,0.5,0.5,0.33,0.25,0.55,0.5,0.5,0.33,0.25,0.55,0.44,0.28,0.25,0.55,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">between the two groups, neither at baseline (p = 0,53) nor at 6 </text>
   <text y="319.059" x="310.016,317.018,321.518,326.018,328.52,333.02,336.521,338.69,341.687,346.187,351.263,355.763,358.013,362.513,367.013,370.01,372.26,374.429,380.432,384.932,387.434,391.934,394.103,398.603,401.6,406.1,410.6,415.1,418.601,420.77,425.27,429.266,433.766,435.935,439.931,442.1,445.601,448.103,452.603,457.103,459.605,462.602,465.104,469.1,473.096,477.596,480.098,482.267,486.263,490.763,494.759,499.259,503.759,507.755,509.924,514.424,517.421,519.59,525.593,531.596,536.933,543.431,545.681" svgx:width="0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.33,0.5,0.56,0.5,0.25,0.5,0.5,0.33,0.25,0.25,0.67,0.5,0.28,0.5,0.25,0.5,0.33,0.5,0.5,0.5,0.39,0.25,0.5,0.44,0.5,0.25,0.44,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25,0.44,0.5,0.44,0.5,0.5,0.44,0.25,0.5,0.33,0.25,0.67,0.67,0.72,0.72,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">months (p=0,16). Both groups had a significant change of BCVA, </text>
   <text y="330.057" x="310.016,314.516,319.016,321.518,324.371,326.873,331.373,335.369,338.222,340.724,347.726,352.226,355.223,359.723,364.223,368.219,375.221,379.217,383.717,386.219,389.072,395.57,399.566,403.067,405.92,410.42,414.92,417.422,420.275,423.776,426.278,430.778,435.278,437.78,440.777,443.279,447.275,451.271,455.771,458.273,460.775,465.275,468.128,472.628,475.13,477.965,480.962,484.958,487.955,491.951,496.451,498.953,501.806,506.306,510.302,512.804,519.302,523.298,527.294,531.794,534.647,537.149,541.649,545.645" svgx:width="0.5,0.5,0.28,0.25,0.28,0.5,0.44,0.25,0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.78,0.44,0.5,0.28,0.25,0.72,0.44,0.39,0.25,0.5,0.5,0.28,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.25,0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">but the improvement was not significantly different between the </text>
   <text y="341.055" x="310.016,312.518,319.016,323.516,325.766,330.266,333.263,337.763,342.263,346.763,350.264,352.514,355.511,360.011,365.087,369.587,371.837,376.337,380.837,383.834" svgx:width="0.28,0.72,0.5,0.25,0.5,0.33,0.5,0.5,0.5,0.39,0.25,0.33,0.5,0.56,0.5,0.25,0.5,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">two groups (p=0,75).</text>
   <text y="352.053" x="310.016,316.514,321.014,326.018,330.014,332.516,337.52,341.021,343.523,348.023,353.027,356.528,359.525" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="352.053" x="361.766,367.769,371.765,376.265,378.767,382.763,385.265,389.765,394.265,396.506,403.508,407.504,410.006,414.002,418.502,420.743,424.739,429.239,433.739,440.741,444.737,447.239,451.739,455.24,459.236,463.736,468.236,472.736,474.977,478.973,483.473,487.973,490.475,494.975,497.216,501.716,505.712,507.953,511.949,514.19,518.69,523.19,525.692,529.688,534.188,536.69,539.192,543.188,545.69" svgx:width="0.67,0.44,0.5,0.28,0.44,0.28,0.5,0.5,0.25,0.78,0.44,0.28,0.44,0.5,0.25,0.44,0.5,0.5,0.78,0.44,0.28,0.5,0.39,0.44,0.5,0.5,0.5,0.25,0.44,0.5,0.5,0.28,0.5,0.25,0.5,0.44,0.25,0.44,0.25,0.5,0.5,0.28,0.44,0.5,0.28,0.28,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Rayleigh match anomaloscopy could be a potential </text>
   <text y="363.051" x="310.016,314.516,317.513,322.013,326.513,331.013,335.513,339.014,341.516,344.018,348.014,350.264,350.948,357.95,361.946,364.943,369.443,373.439,376.436,378.686,379.37,382.367,386.867,389.864,392.114,392.798,398.801,404.804,410.141,416.144,418.394,419.078,423.578,425.828,426.512,433.514,438.014,442.514,445.016,449.516,453.017,455.267,455.951,459.947,462.944,465.446,469.442,472.439,474.689,475.373,479.369,483.869,486.119,486.803,490.799,495.299,497.801,501.302,505.802,510.302,514.298,516.548,517.232,521.732,524.729,526.979,527.663,532.163,536.663,539.165,541.667,545.663" svgx:width="0.5,0.33,0.5,0.5,0.5,0.5,0.39,0.28,0.28,0.44,0.25,0.55,0.78,0.44,0.33,0.5,0.44,0.33,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.67,0.67,0.72,0.72,0.25,0.55,0.5,0.25,0.55,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.55,0.44,0.33,0.28,0.44,0.33,0.25,0.55,0.44,0.5,0.25,0.55,0.44,0.5,0.28,0.39,0.5,0.5,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.5,0.28,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">prognostic marker for BCVA 6 months after an episode of optic </text>
   <text y="374.049" x="310.016,314.516,318.512,323.012,326.009,328.511,331.013,333.515,337.016,339.266,341.516,344.252,350.255,354.755,359.255,361.757,364.754,368.75,372.251,374.753,377.003,379.739,383.24,387.236,391.736,395.237,397.739,400.241,402.743,407.243,409.745,412.247,416.747,418.997,421.733,425.729,430.229,434.729,436.979,439.715,442.217,446.717,450.713,452.963,455.699,460.199,464.699,468.695,471.692,475.688,478.19,480.692,482.942,485.678,489.674,492.176,496.172,499.673,503.174,505.676,508.673,511.175,515.171,519.167,521.669,524.171,528.671,533.171,535.421,538.157,542.657,545.654" svgx:width="0.5,0.44,0.5,0.33,0.28,0.28,0.28,0.39,0.25,0.25,0.55,0.67,0.5,0.5,0.28,0.33,0.44,0.39,0.28,0.25,0.55,0.39,0.44,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.5,0.44,0.33,0.44,0.28,0.28,0.25,0.55,0.44,0.28,0.44,0.39,0.39,0.28,0.33,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">neuritis. Contrast sensitivity and the overall classification of </text>
   <text y="385.047" x="310.016,316.019,322.517,327.521,332.192,337.025,339.275,341.525,346.025,350.525,354.521,358.022,360.272,364.772,369.272,371.774,374.024,377.525,381.521,385.517,392.519,394.769,397.271,401.771,404.021,408.521,412.517,417.017,421.013,423.263,425.765,430.265,432.767,436.268,438.518,443.018,447.518,450.02,454.016,458.516,461.018,463.52,467.516,470.018" svgx:width="0.67,0.72,0.56,0.61,0.61,0.25,0.25,0.5,0.5,0.44,0.39,0.25,0.5,0.5,0.28,0.25,0.39,0.44,0.44,0.78,0.25,0.28,0.5,0.25,0.5,0.44,0.5,0.44,0.25,0.28,0.5,0.28,0.39,0.25,0.5,0.5,0.28,0.44,0.5,0.28,0.28,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">RNFLT, does not seem to have this potential.</text>
   <text y="396.045" x="310.016,315.515,320.015,324.011,327.512,331.508,333.965,336.962,340.958,344.459,348.959,351.461,353.963,357.464,359.912,363.908,366.905,370.901,373.358,376.355,379.352,383.852,390.854,393.311,397.307,401.807,404.264,408.764,413.264,417.764,422.264,424.766,429.266,433.766,436.223,439.724,442.226,446.726,451.226,455.141,457.391,459.848,463.844,468.344,472.844,475.301,482.303,486.803,489.8,493.796,496.244,500.24,504.74,507.242,511.238,515.738,519.239,521.741,526.241,530.237,532.694,536.69,541.19,545.69" svgx:width="0.61,0.5,0.44,0.39,0.44,0.25,0.33,0.44,0.39,0.5,0.28,0.28,0.39,0.25,0.44,0.33,0.44,0.25,0.33,0.33,0.5,0.78,0.25,0.44,0.5,0.25,0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.25,0.44,0.5,0.5,0.25,0.78,0.5,0.33,0.44,0.25,0.44,0.5,0.28,0.44,0.5,0.39,0.28,0.5,0.44,0.25,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">These results are from an ongoing study, and more extensive and </text>
   <text y="407.043" x="310.016,314.516,318.512,321.014,325.01,327.512,330.014,334.01,338.51,340.76,345.26,349.256,351.758,355.754,358.004,364.502,367.004,369.506,372.008,374.258,378.758,382.754,385.004,389.504,392.501,396.497,399.998,403.994,408.494,410.996,414.992,419.492,421.742,424.244,428.744,430.994,433.496,437.996,441.992,444.242,447.239,451.739,454.241,458.741,461.738,465.734" svgx:width="0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.25,0.5,0.44,0.28,0.44,0.25,0.72,0.28,0.28,0.28,0.25,0.5,0.44,0.25,0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.44,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.33,0.5,0.28,0.5,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">detailed data will be presented in the future.</text>
   <text y="434.043" x="310.016,315.515,320.015,324.515" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P763</text>
   <text y="445.041" x="310.016,313.517,318.521,323.021,327.017,330.518,333.515,336.017,340.517,345.017,348.014,350.516,355.016,360.02,362.27,366.77,369.767,372.017,377.021,381.521,383.771,387.767,392.267,394.769,399.773,403.769,408.773,412.769,416.765,419.015,423.515,426.512,428.762,433.766,436.268,439.769,443.765,448.265,451.766,455.762,458.012,462.512,466.508,469.505,472.007,476.507,479.009,482.006,486.506,488.756,491.753,498.251,504.254,510.752,517.25,520.247" svgx:width="0.39,0.56,0.5,0.44,0.39,0.33,0.28,0.5,0.5,0.33,0.28,0.5,0.56,0.25,0.5,0.33,0.25,0.56,0.5,0.25,0.44,0.5,0.28,0.56,0.44,0.56,0.44,0.44,0.25,0.5,0.33,0.25,0.56,0.28,0.39,0.44,0.5,0.39,0.44,0.25,0.5,0.44,0.33,0.28,0.5,0.28,0.33,0.5,0.25,0.33,0.72,0.67,0.72,0.72,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Investigation of no evidence of disease activity (NEDA) </text>
   <text y="456.039" x="310.016,314.516,319.52,324.524,326.774,329.276,333.776,338.78,343.28,346.277,349.274,353.27,357.266,364.763,367.013,372.017,374.519,378.02,382.52,387.524,390.026,392.528,395.03,398.027,402.527,404.777,409.781,413.777,417.773,422.777,425.279,429.275,432.272,434.774,439.274,444.278,446.528,449.03,454.034,456.284,460.784,463.034,466.535,470.531,475.031,479.027,484.031,486.281,490.781,494.777,499.277,503.273" svgx:width="0.5,0.56,0.56,0.25,0.28,0.5,0.56,0.5,0.33,0.33,0.44,0.44,0.83,0.25,0.56,0.28,0.39,0.5,0.56,0.28,0.28,0.28,0.33,0.5,0.25,0.56,0.44,0.44,0.56,0.28,0.44,0.33,0.28,0.5,0.56,0.25,0.28,0.56,0.25,0.5,0.25,0.39,0.44,0.5,0.44,0.56,0.25,0.5,0.44,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">and long-term disability prediction in a seven year </text>
   <text y="467.037" x="310.016,312.518,317.018,322.022,326.522,329.024,332.021,337.025,342.029,344.531,349.535,354.035,356.537,358.787,367.283,372.287,374.537,378.533,383.033,388.037,392.537,396.533" svgx:width="0.28,0.5,0.56,0.5,0.28,0.33,0.56,0.56,0.28,0.56,0.5,0.28,0.25,0.94,0.56,0.25,0.44,0.5,0.56,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">longitudinal MS cohort</text>
   <text y="478.035" x="310.016,316.514,322.013,324.263,330.266,334.766,337.268,340.769,343.271,347.267,349.769" svgx:width="0.72,0.61,0.25,0.67,0.5,0.28,0.39,0.28,0.44,0.28,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">DL Rotstein</text>
   <text y="475.583" x="354.268" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="478.103" x="357.193,359.443,361.693,367.696,373.699,375.949,382.447,386.443,390.439,392.941" svgx:width="0.25,0.25,0.67,0.67,0.25,0.72,0.44,0.44,0.28,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, BC Healy</text>
   <text y="475.583" x="397.441" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="478.103" x="400.366,402.616,404.866,412.867,418.366,420.616,428.617,432.613,435.115,437.617" svgx:width="0.25,0.25,0.89,0.61,0.25,0.89,0.44,0.28,0.28,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, MT Malik</text>
   <text y="475.583" x="442.116" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="478.103" x="445.041,447.291,449.541,455.04,457.29,463.293,467.793,470.295,472.797,477.297,479.799" svgx:width="0.25,0.25,0.61,0.25,0.67,0.5,0.28,0.28,0.5,0.28,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, T Chitnis</text>
   <text y="475.583" x="483.3" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="478.103" x="486.225,488.475,490.725,497.223,502.722" svgx:width="0.25,0.25,0.72,0.61,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, HL </text>
   <text y="489.101" x="310.014,318.51,322.506,325.008,329.508,333.504" svgx:width="0.94,0.44,0.28,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Weiner</text>
   <text y="486.583" x="336.502" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="497.581" x="310.013" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="500.103" x="312.941,318.44,321.941,324.443,328.943,333.443,337.943,344.441,346.691,351.191,355.691,360.191,362.441,369.938,374.438,380.936,384.932,389.432,392.429,395.93,398.18,404.678,409.178,412.679,417.179,419.681,422.183,426.683,429.185,431.435,433.685,440.183,444.683,448.184,452.18,456.68,460.181,464.681,466.931,474.428,478.424,482.924,485.426,489.422,493.922,496.424,498.674,503.174,507.17,511.67,516.17,520.67,523.172,525.422" svgx:width="0.61,0.39,0.28,0.5,0.5,0.5,0.72,0.25,0.5,0.5,0.5,0.25,0.83,0.5,0.72,0.44,0.5,0.33,0.39,0.25,0.72,0.5,0.39,0.5,0.28,0.28,0.5,0.28,0.25,0.25,0.72,0.5,0.39,0.44,0.5,0.39,0.5,0.25,0.83,0.44,0.5,0.28,0.44,0.5,0.28,0.25,0.5,0.44,0.5,0.5,0.5,0.28,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Brigham and Women’s Hospital, Harvard Medical School, </text>
   <text y="511.101" x="310.016,316.019,320.015,324.515,328.016,332.516,335.018,339.518,344.018,348.014,350.264,352.514,358.013,362.513,366.014,368.516,373.016,377.516,379.766,382.016,389.513,395.012,397.262,399.512,406.01,410.51,413.012,415.514,419.51,424.01,426.26,430.76,433.262,437.762,440.264,444.26" svgx:width="0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.25,0.61,0.5,0.39,0.28,0.5,0.5,0.25,0.25,0.83,0.61,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Neurology, Boston, MA, United States</text>
   <text y="538.101" x="310.016,316.019,320.519,324.515,329.519,334.019,337.853,342.353,347.357,352.361,357.365,360.362" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="538.101" x="364.124,370.622,376.121,382.619,388.622,390.872,392.384,396.884,400.88,404.381,406.631,408.143,412.643,416.639,420.635,425.135,432.137,436.133,438.383,439.895,443.891,448.391,450.641,452.153,454.655,461.657,466.157,470.657,473.654,476.156,480.152,484.652,487.154,489.404,490.916,494.417,498.413,502.409,506.909,511.409,515.909,519.905,522.902,527.402,529.652,531.164,535.664,540.164,542.666" svgx:width="0.72,0.61,0.72,0.72,0.25,0.55,0.5,0.44,0.39,0.25,0.55,0.5,0.44,0.44,0.5,0.78,0.44,0.25,0.55,0.44,0.5,0.25,0.55,0.28,0.78,0.5,0.5,0.33,0.28,0.44,0.5,0.28,0.25,0.55,0.39,0.44,0.44,0.5,0.5,0.5,0.44,0.33,0.5,0.25,0.55,0.5,0.5,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">NEDA has become an important secondary out-</text>
   <text y="549.099" x="310.016,314.012,318.512,325.514,329.51,331.76,332.552,339.554,343.55,347.546,351.047,355.547,358.544,362.54,364.79,365.582,368.084,372.584,374.834,375.626,383.627,388.631,390.881,391.673,395.669,398.171,400.673,405.173,407.675,411.671,415.667,418.169,420.419,421.211,423.713,426.71,429.212,433.208,435.71,439.211,441.461,443.711,444.503,449.003,453.503,456.005,458.255,459.047,461.549,464.051,467.552,469.802,470.594,475.094,478.091,482.087,486.587,489.089,493.085,495.587,498.089,502.589,506.585,508.835,509.627,514.127,518.627,525.125,529.121,532.118,534.368,535.16,538.157,542.657,545.654" svgx:width="0.44,0.5,0.78,0.44,0.25,0.55,0.78,0.44,0.44,0.39,0.5,0.33,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.89,0.56,0.25,0.55,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.28,0.33,0.28,0.44,0.28,0.39,0.25,0.25,0.55,0.5,0.5,0.28,0.25,0.55,0.28,0.28,0.39,0.25,0.55,0.5,0.33,0.44,0.5,0.28,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.5,0.5,0.72,0.44,0.33,0.25,0.55,0.33,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">come measure in MS clinical trials, but its predictive power for </text>
   <text y="560.097" x="310.016,312.518,317.018,321.518,326.018,329.015,331.517,335.513,338.51,345.512,347.762,352.262,354.764,358.265,362.261,366.761,369.263,371.765,374.267,376.769,381.269,383.519,387.02,389.522,393.518,396.02,400.52,404.021,406.271,410.771,414.767,418.268,420.518,425.018,429.518,432.02,434.27,438.77,442.766,446.762,451.262,453.512,457.508,462.008,466.508,469.01,473.51,476.507,480.503,485.003" svgx:width="0.28,0.5,0.5,0.5,0.33,0.28,0.44,0.33,0.78,0.25,0.5,0.28,0.39,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.39,0.28,0.44,0.28,0.5,0.39,0.25,0.5,0.44,0.39,0.25,0.5,0.5,0.28,0.25,0.5,0.44,0.44,0.5,0.25,0.44,0.5,0.5,0.28,0.5,0.33,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">long-term disability status has not been explored.</text>
   <text y="571.095" x="310.016,317.018,322.022,325.019,329.015,333.011,336.008,338.51,343.01,347.006,350.507,353.504" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="571.095" x="356.708,361.577,366.077,368.327,369.281,371.783,376.283,380.783,384.779,388.28,390.782,393.284,397.784,401.78,404.282,408.278,410.528,411.482,417.98,423.479,429.977,435.98,438.23,439.184,443.684,448.184,452.18,455.177,457.427,458.381,462.881,465.131,466.085,470.585,474.581,478.577,481.574,485.075,487.325,488.279,492.275,495.776,498.026,498.98,505.982,509.978,513.974,517.475,521.975,524.972,528.968,533.468,535.718,536.672,541.172,545.672" svgx:width="0.61,0.5,0.25,0.55,0.28,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.44,0.28,0.44,0.25,0.55,0.72,0.61,0.72,0.72,0.25,0.55,0.5,0.5,0.44,0.33,0.25,0.55,0.5,0.25,0.55,0.5,0.44,0.44,0.33,0.39,0.25,0.55,0.44,0.39,0.25,0.55,0.78,0.44,0.44,0.39,0.5,0.33,0.44,0.5,0.25,0.55,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">To investigate NEDA over 7 years as measured by </text>
   <text y="582.093" x="310.016,313.013,317.009,319.511,323.507,328.007,331.508,335.504,339.005,341.255,343.505,344.711,349.211,351.713,355.214,359.21,363.71,366.212,368.714,371.216,373.718,378.218,380.468,381.665,386.165,389.162,393.662,398.162,401.159,405.155,408.656,412.157,414.659,419.159,423.659,425.909,428.159,429.365,433.361,437.861,442.361,444.611,445.817,450.317,454.313,458.309,461.306,463.808,468.308,470.558,471.764,479.765,485.768,488.765,492.266,494.516,496.766,497.972,501.968,506.468,510.968,513.2180000000001,514.424,516.926,521.426,523.676,524.882,529.382,533.378,535.88,539.876,542.675" svgx:width="0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.39,0.25,0.25,0.55,0.5,0.28,0.39,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.55,0.5,0.33,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.44,0.44,0.33,0.28,0.5,0.25,0.55,0.89,0.67,0.33,0.39,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.33,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">relapses, disability progression, and yearly MRIs, and to deter-</text>
   <text y="593.091" x="310.016,317.018,319.52,324.02,328.016,330.338,332.84,337.34,341.336,343.658,348.158,351.155,355.151,359.651,362.153,366.149,368.651,371.153,375.653,379.649,381.971,386.471,390.467,392.969,397.469,401.465,403.787,408.287,411.284,413.606,420.104,425.603,432.101,438.104,440.426,444.422,448.922,453.422,457.922,461.918,464.42,466.922,471.422,473.744,476.741,481.241,484.238,486.56,490.556,495.056,499.052,503.552,508.052,512.048,514.37,516.872,521.372,523.694,529.193,535.691,540.695,545.699" svgx:width="0.78,0.28,0.5,0.44,0.25,0.28,0.5,0.44,0.25,0.5,0.33,0.44,0.5,0.28,0.44,0.28,0.28,0.5,0.44,0.25,0.5,0.44,0.28,0.5,0.44,0.25,0.5,0.33,0.25,0.72,0.61,0.72,0.72,0.25,0.44,0.5,0.5,0.5,0.44,0.28,0.28,0.5,0.25,0.33,0.5,0.33,0.25,0.44,0.5,0.44,0.5,0.5,0.44,0.25,0.28,0.5,0.25,0.61,0.72,0.56,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">mine the predictive value of NEDA annually for change in EDSS </text>
   <text y="604.089" x="310.016,314.012,318.512,323.012,325.262,327.764,330.266,337.268,341.264,345.764,348.014,352.514,357.014,359.264,362.261,366.761,371.261,373.763,376.013,382.511,386.507,389.009,393.509,395.759,398.756,404.255,408.755,413.255,418.259,426.755,429.752,432.002,435.998,438.5,440.75,445.25,447.5,452.0,455.996,459.992,462.989,466.49" svgx:width="0.44,0.5,0.5,0.25,0.28,0.28,0.78,0.44,0.5,0.25,0.5,0.5,0.25,0.33,0.5,0.5,0.28,0.25,0.72,0.44,0.28,0.5,0.25,0.33,0.61,0.5,0.5,0.56,0.94,0.33,0.25,0.44,0.28,0.25,0.5,0.25,0.5,0.44,0.44,0.33,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and timed 25 foot walk (T25FW) at 7 years.</text>
   <text y="615.087" x="310.016,318.467,322.418,325.37,330.329,334.784,339.743,343.199,346.151" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="615.087" x="349.796,354.755,358.706,361.163,363.62,367.571,372.026,374.483,377.939,380.189,381.584,384.536,387.488,391.943,398.9,401.15,402.545,405.002,409.457,413.408,415.658,417.053,423.011,428.465,431.417,439.373,445.331,447.581,448.976,453.935,456.392,460.847,465.302,469.757,472.007,473.402,477.353,479.81,482.06,483.455,485.912,490.367,494.318,496.568,497.962,503.921,506.872,509.329,513.784,518.24,522.19,529.147,531.397,532.792,536.743,541.198,545.698" svgx:width="0.56,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.33,0.33,0.5,0.78,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.67,0.61,0.33,0.89,0.67,0.25,0.55,0.56,0.28,0.5,0.5,0.5,0.25,0.55,0.44,0.28,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.67,0.33,0.28,0.5,0.5,0.44,0.78,0.25,0.55,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Patients from the CLIMB Study at the Brigham and </text>
   <text y="626.085" x="310.016,317.747,322.202,329.159,333.11,337.565,340.022,343.478,345.683,352.136,356.591,360.047,364.502,366.959,369.416,373.367,375.824,378.029,384.482,388.433,391.385,395.336,397.541,399.998,404.453,408.404,410.861,415.315,419.77,423.721,428.176,430.381,432.838,435.79,437.995,440.452,444.907,448.858,453.313,455.518,459.973,463.924,468.379,470.584,474.535,476.74,481.195,483.652,487.603,492.058,496.513,500.968,504.424,506.881,510.337,512.542,516.997,519.949,522.154,528.112,531.064,536.023,538.228,542.683,545.68" svgx:width="0.94,0.5,0.78,0.44,0.5,0.33,0.39,0.25,0.72,0.5,0.39,0.5,0.28,0.28,0.44,0.28,0.25,0.72,0.44,0.33,0.44,0.25,0.28,0.5,0.44,0.28,0.5,0.5,0.44,0.5,0.25,0.28,0.33,0.25,0.28,0.5,0.44,0.5,0.25,0.5,0.44,0.5,0.25,0.44,0.25,0.5,0.28,0.44,0.5,0.5,0.5,0.39,0.28,0.39,0.25,0.5,0.33,0.25,0.67,0.33,0.56,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Women’s Hospital were included if they had a diagnosis of CIS or </text>
   <text y="637.083" x="310.016,315.974,321.932,329.888,334.847,337.664,341.615,346.07,350.525,353.342,357.293,359.75,362.567,365.024,368.975,372.926,376.382,378.839,381.656,386.111,388.928,393.383,397.334,401.285,404.237,407.693,410.509,414.964,417.916,420.733,425.188,428.14,432.595,436.051,440.506,444.457,448.408,450.865,453.322,457.777,461.728,464.545,467.497,471.952,474.409,476.866,481.321,487.774,490.726,495.181,499.636,501.841,504.658,511.111,516.565,523.018,528.976,531.793,538.246,542.197,545.698" svgx:width="0.67,0.67,0.89,0.56,0.25,0.44,0.5,0.5,0.25,0.44,0.28,0.25,0.28,0.44,0.44,0.39,0.28,0.25,0.5,0.25,0.5,0.44,0.44,0.33,0.39,0.25,0.5,0.33,0.25,0.5,0.33,0.5,0.39,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.33,0.5,0.28,0.28,0.5,0.72,0.33,0.5,0.5,0.25,0.25,0.72,0.61,0.72,0.72,0.25,0.72,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">RRMS and at least 7 years of prospective follow-up. NEDA was </text>
   <text y="648.081" x="310.016,314.471,318.422,321.374,323.831,328.286,332.237,336.692,338.942,339.707,344.162,348.617,350.867,351.632,354.089,358.544,362.495,364.745,365.51,369.461,373.916,377.372,381.323,385.778,389.729,393.68,395.93,396.695,401.15,404.102,406.352,407.117,410.069,414.02,416.477,420.428,424.883,428.339,432.289,435.745,437.95,440.2,440.965,444.421,448.876,452.332,454.789,458.74,461.197,465.652,469.603,474.058,476.308,477.073,482.527,488.98,493.939,498.898,501.148,501.913,506.368,509.32,513.775,518.23,521.182,525.133,528.589,532.045,534.502,538.957,543.412,545.662" svgx:width="0.5,0.44,0.33,0.28,0.5,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.39,0.44,0.5,0.44,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.39,0.25,0.25,0.55,0.39,0.5,0.39,0.28,0.44,0.28,0.5,0.44,0.5,0.25,0.55,0.61,0.72,0.56,0.56,0.25,0.55,0.5,0.33,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">defined by the absence of relapses, sustained EDSS progression, </text>
   <text y="659.079" x="310.016,313.967,318.422,322.877,325.127,325.883,330.338,334.289,340.742,343.586,349.04,353.495,355.745,356.501,360.956,363.908,366.752,372.206,376.661,378.911,379.667,384.122,388.073,392.528,396.983,399.44,401.897,406.352,408.809,413.264,420.221,423.173,427.124,431.579,436.034,439.985,444.44,448.391,450.848,455.303,459.758,462.008,462.764,465.221,469.172,472.628,475.085,479.539,483.994,487.45,489.7,490.456,494.407,496.864,499.114,499.87,503.821,508.276,512.731,517.186,521.137,523.594,525.844,526.6,529.057,533.512,535.969,539.92,542.675" svgx:width="0.44,0.5,0.5,0.25,0.55,0.5,0.44,0.72,0.25,0.61,0.5,0.25,0.55,0.5,0.33,0.25,0.61,0.5,0.25,0.55,0.5,0.44,0.5,0.5,0.28,0.28,0.5,0.28,0.5,0.78,0.33,0.44,0.5,0.5,0.44,0.5,0.44,0.28,0.5,0.5,0.25,0.55,0.28,0.44,0.39,0.28,0.5,0.5,0.39,0.25,0.55,0.44,0.28,0.25,0.55,0.44,0.5,0.5,0.5,0.44,0.28,0.25,0.55,0.28,0.5,0.28,0.44,0.33,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and new T2 or T1 gadolinium-enhancing lesions at annual inter-</text>
   <text y="670.077" x="310.016,314.471,318.422,320.879,324.335,326.54,328.79,330.59,335.549,339.5,341.957,344.414,348.365,352.82,355.277,358.733,360.983,362.783,369.236,373.187,376.139,380.09,382.34,384.14,388.091,392.546,396.497,398.954,403.409,407.359,411.31,415.765,418.015,419.815,422.272,426.727,431.182,435.133,439.588,443.539,447.994,452.449,456.4,460.855,463.312,465.562,467.362,471.817,474.769,477.019,478.819,483.274,485.731,489.187,493.138,497.089,500.545,504.496,506.746,508.546,515.503,519.958,524.413,526.87,529.822,534.277,536.734,541.189,545.689" svgx:width="0.5,0.44,0.28,0.39,0.25,0.25,0.55,0.56,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.44,0.44,0.5,0.25,0.55,0.28,0.5,0.5,0.44,0.5,0.44,0.5,0.5,0.44,0.5,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.55,0.78,0.5,0.5,0.28,0.33,0.5,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">vals. Patients were analyzed independent of disease modifying </text>
   <text y="681.075" x="310.016,312.473,316.928,320.879,323.831,327.782,332.237,336.107,338.312,340.463,345.917,350.372,354.323,357.275,361.226,363.539,369.992,373.943,376.895,380.846,383.159,387.614,392.069,396.523,398.836,402.292,406.747,411.202,413.659,417.61,421.561,424.018,427.474,429.787,436.24,438.697,441.154,445.609,447.922,452.377,456.328,460.279,463.231,465.688,470.143,472.456,476.911,479.863,483.814,486.271,490.726,493.039,500.995,506.953,509.905,512.218,516.169,520.624,525.079,527.392,531.847,534.304,538.255,542.71" svgx:width="0.28,0.5,0.44,0.33,0.44,0.5,0.5,0.25,0.25,0.61,0.5,0.44,0.33,0.44,0.25,0.72,0.44,0.33,0.44,0.25,0.5,0.5,0.5,0.25,0.39,0.5,0.5,0.28,0.44,0.44,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.5,0.44,0.44,0.33,0.28,0.5,0.25,0.5,0.33,0.44,0.28,0.5,0.25,0.89,0.67,0.33,0.25,0.44,0.5,0.5,0.25,0.5,0.28,0.44,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">therapy. There were 219 subjects with yearly brain MRI and bian-</text>
   <text y="692.073" x="310.016,314.471,318.926,322.877,325.334,327.584,329.312,333.263,335.72,338.177,342.632,345.089,349.04,352.991,355.448,357.698,359.426,363.881,366.338,369.794,372.251,374.708,378.164,380.369,382.619,384.347,389.306,393.761,396.218,400.673,404.624,407.081,409.331,411.059,415.01,419.465,422.417,426.871,429.121,430.849,433.306,440.263,444.214,448.669,451.126,455.581,460.036,462.286,464.014,470.467,474.418,477.874,480.124,481.852,485.803,490.258,494.209,496.666,499.123,503.074,507.529,509.986,513.937,516.187,517.915,520.867,525.322,528.274,530.524,532.253,536.708,541.163,545.663" svgx:width="0.5,0.5,0.44,0.28,0.25,0.55,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.5,0.28,0.39,0.28,0.28,0.39,0.25,0.25,0.55,0.56,0.5,0.28,0.5,0.44,0.28,0.25,0.55,0.44,0.5,0.33,0.5,0.25,0.55,0.28,0.78,0.44,0.5,0.28,0.5,0.5,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.44,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.44,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">nual clinical visits. Spinal cord imaging was available for 162 </text>
   <text y="703.071" x="310.016,312.968,317.423,321.878,329.33,332.282,334.802,338.753,343.208,347.663,350.021,355.475,359.93,364.385,369.344,377.633,380.153,384.608,388.559,391.016,394.967,397.487,400.439,404.894,407.846,410.366,414.82,419.275,423.73,426.25,429.202,433.657,438.112,445.564,448.516,450.721,453.079,458.533,462.988,466.939,469.459,473.914,478.369,481.825,484.282,486.739,489.196,493.651,497.602,500.122,504.073,508.528,512.983,515.503,519.958,523.909,528.364,532.315,534.772,537.229,541.684,545.68" svgx:width="0.33,0.5,0.5,0.83,0.33,0.25,0.44,0.5,0.5,0.25,0.61,0.5,0.5,0.56,0.94,0.25,0.5,0.44,0.28,0.44,0.25,0.33,0.5,0.33,0.25,0.5,0.5,0.5,0.25,0.33,0.5,0.5,0.83,0.33,0.25,0.25,0.61,0.5,0.44,0.25,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.25,0.44,0.5,0.5,0.25,0.5,0.44,0.5,0.44,0.28,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(74%) and T25FW data for 145 (66%). The positive and negative </text>
   <text y="714.069" x="310.016,314.471,317.423,321.374,325.829,328.286,332.237,334.694,337.151,341.606,345.557,347.375,351.83,355.781,358.238,362.693,366.644,370.1,371.918,374.87,379.829,384.788,390.08,392.285,394.103,400.556,405.515,411.968,414.92,416.738,421.193,424.145,425.963,432.416,437.87,444.323,450.281,452.099,455.051,459.506,462.458,464.276,469.73,476.183,481.142,486.101,487.919,491.87,496.325,500.276,504.73,509.185" svgx:width="0.5,0.33,0.44,0.5,0.28,0.44,0.28,0.28,0.5,0.44,0.25,0.5,0.44,0.28,0.5,0.44,0.39,0.25,0.33,0.56,0.56,0.72,0.25,0.25,0.72,0.56,0.72,0.33,0.25,0.5,0.33,0.25,0.72,0.61,0.72,0.72,0.25,0.33,0.5,0.33,0.25,0.61,0.72,0.56,0.56,0.25,0.44,0.5,0.44,0.5,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">predictive values (PPV, NPV) of NEDA for EDSS change</text>
   <text y="714.069" x="513.136" svgx:width="0.55" style="fill:rgb(0,0,0);font-family:SymbolMT;font-size:9.0px;stroke:none;">≤</text>
   <text y="714.069" x="518.015,519.833,524.288,526.493,530.948,532.766,536.717,541.172,545.672" svgx:width="0.25,0.5,0.25,0.5,0.25,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> 0.5 and </text>
   <text y="725.067" x="310.016,314.471,318.926,321.293,324.749,327.206,331.661,336.116,338.573,341.525,343.982,347.933,351.884,356.339,358.796,361.001,366.455,370.91,375.365,380.324,388.613,390.98,394.931,399.386,403.337,407.792,412.247,416.198,418.565,422.516,424.973,427.34,431.794,434.161,438.616,442.567,446.518,449.47,452.926,455.293,461.746,465.697,468.649,472.6,474.967,478.918,482.869,485.326,489.277,493.732,496.189,500.14,502.597,506.548,511.003,513.37,517.321,521.776,526.231,530.686,534.637,537.094,539.551,543.421,545.671" svgx:width="0.5,0.5,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25,0.61,0.5,0.5,0.56,0.94,0.25,0.44,0.5,0.44,0.5,0.5,0.44,0.25,0.44,0.28,0.25,0.5,0.25,0.5,0.44,0.44,0.33,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.44,0.28,0.44,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.44,0.5,0.5,0.5,0.44,0.28,0.28,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">no significant T25FW change at 7 years were calculated annually. </text>
  </g>
 </g>
</svg>
